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ABSTRACT 
 
 Over the past 20 years researchers and health care practitioners have come to 
realize in addition to high prevalence rates, individuals with co-occurring disorders did 
not represent a homogeneous group (Drake, et al., 1998: 2001; Lehman, et al., 1994: 
2000; Mueser, et al., 2000). It is essential to consider the heterogeneity of co-occurring 
disorders when considering new treatment modalities. Thus, it becomes pivotal to 
identify these differences for treatment approaches and program goals. Research shows 
that heterogeneity of treatment populations can be reduced through empirically-derived 
homogeneous groups based on multivariate analysis (Ries, et al., 1993; Lehman et al., 
2000; Mueser, et al., 2000).    
 The purpose of the current study was to address a significant void in knowledge 
on the heterogeneity of co-occurring disorders by determining if homogeneous subgroups 
exist within an outpatient population presenting for treatment and if so how many groups 
exist and what makes up group membership. Identification of subgroups can provide a 
mechanism to better understand the interrelationships between determinants that 
contribute to the etiology and problem severity at an individual and group level. 
Secondly, in an effort to improve service delivery, empirically-derived subgroups hold 
important clinical implications for treatment models.  
 The exploratory research was conducted through a retrospective analysis seeking 
a parsimonious model of subgroups made up of individuals with co-occurring disorders 
entering an outpatient program using a latent class analysis (LCA). The best fitting 
statistical model in the latent class analysis was one in which the overall sample was 
composed of three (3) subgroups. The three-class model that included alcohol use, illegal 
drug use, education level and serious depression was identified as best fitting the data. 
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CHAPTER I 
INTRODUCTION 
 
Description and Background of the Problem 
 The U.S. Department of Health and Human Services (1999) reported on the 
difficulty the co-occurring population faces in seeking and receiving diagnostic and 
treatment services, even though, separately, these disorders are often assessed and 
temporarily treated successfully. For clinicians, the greatest challenge serving consumers 
with co-occurring disorders is deciding on the most appropriate locus of their care. 
Consumers with co-occurring disorders represent a widely diverse population who are 
broadly distinct in terms of their service needs. Co-occurring disorders are not a unitary 
construct, bur rather a disease concept that represents a distinct population (Luke, 
Mowbray, Klump, Herman, and Boots Miller, 1996).  Such a population can not be 
treated with a single approach (Minkoff, 2000), but rather by consumer-specific plans of 
care. Consumers presenting for treatment have different service needs and varying 
degrees of functioning abilities and motivation to participate in treatment. The very 
nature of providing care for individuals with co-occurring disorders is a treatment 
approach that is flexible and based on the specific needs and realities of an individual. 
 The heterogeneity of this population can be partially explained by the interaction 
of substance abuse and psychiatric symptoms and how that interaction affects an 
individual’s ability to care for self. Although each individual is unique, there is a 
potential benefit in identifying subgroups for needs assessment and treatment planning. 
There is considerable evidence that disease management, a managed care initiative, has 
been successful in utilizing subgroups to identify, prevent and treat chronic illness, such 
as diabetes, cancers, coronary heart disease and asthma (Cousins & Liu, 2003; Lorig, 
Sobel, Ritter, & Laurent, 2001;.Buchner, Butt, DeStefano, Edgren, Suarex & Evans, 
1998; Gillespie, 2002; Minkoff & Cline, 2003). 
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Prevalence of Co-occurring Disorders   
 
 Current epidemiologic studies have clearly established the high occurrence and 
significant impact of co-occurring disorders within the general population (Reiger, et al, 
1990; Anthony et al. 1994; Anthony & Kessler, 2000).  Recent incidence rate studies 
estimate the prevalence of co-occurring disorders affecting adults in the United States to 
be somewhere between 7 million to 10 million (Mueser, et al. 2001; USDHHS, 1999b). 
Furthermore, the number is expected to double in the next 30 years to a minimum of 15 
million (NFCMH, 2003). A report by National Household Survey on Drug Abuse 
(NHSDA, 2000), estimated 14.8 million adults (7.3 % of all adults) 18 or older suffered 
from a serious mental illness (SMI) disorder. Of those with SMI, 6.9 million reported 
receiving some form of mental health treatment within a 12 month period, and 4.3 million 
reported a dependency on alcohol or illicit drugs 
 According to the Epidemiologic Catchment Area (ECA), a random survey of 
more than 20,000 Americans (diagnosed with a co-occurring disorder) taken from five 
geographical areas living in the community and in various institutional settings, found a 
22.5% lifetime prevalence of mental disorders and a third of those who had a mental 
disorder (29%) also had a co-occurring disorder. Among those with an alcohol disorder, 
39.6% had comorbid disorders (Reiger, et al, 1990). The most prevalent mental disorder 
in conjunction with an alcohol disorder was: anxiety disorders (19%), antisocial 
personality disorders (14%), effective disorders (13%) and schizophrenia (4%). The ECA 
examined data collected between 1980 and 1984, and was the first quantitative 
information on co-occurring disorders. 
 Furthermore, a National Comorbidity Survey (NCS) administered a similar study 
between 1990 and 1992, conducting a face to face household survey based on a stratified, 
multistage area probability study of people 15 to 54 years in a non-institutionalized 
population. The study supported the high prevalence rates found in the ECA survey. The 
NCS survey found that individuals with severe mental disorders were at significant risk 
for developing a substance abuse disorder; in particular 47% of individuals with 
schizophrenia also had a substance abuse disorder (more than four times the general 
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population) and 61% of individuals with bi-polar disorders had a substance abuse 
disorder (more than five times the general population). 
 
Perspectives on Co-occurring Disorders 
 Researchers have offered three explanations for the prevalence rate for co-
occurring disorders: (1) the disorders may arise independent of each other; (2) the mental 
disorders (e.g., schizophrenia and mood disorders) may place the individual at greater 
risk for substance abuse disorders; and finally (3) drug abuse intoxication or withdrawal 
may result in temporary mental disorder syndromes. Research has shown that an 
individual with a mental disorder is at increased risk for developing a substance abuse 
disorder, and conversely, that a person with a substance abuse disorder is at increased risk 
for developing a mental disorder. The four models that best synthesize current knowledge 
in the field regarding the etiology of co-occurring disorders are illustrated in the 
following table (Anthony, 1991; Kosten & Ziedonis, 1997; Kushner & Mueser, 1993; 
Weiss & Collins, 1992) (See Appendix A). 
 Mueser and colleagues (1998) tested these theories of increased co-morbidity and 
found the evidence suggests a connection between antisocial personality disorders and 
increased morbidity (example of the common factor model).  In the second model, 
(secondary substance abuse disorder) there is evidence supporting a super sensitivity 
concept  assuming  a person with a mental disorder is biologically vulnerable to develop 
a substance abuse disorder if they use even small amounts of alcohol  or other drugs. In 
the third model, Schuckit (1996) examined the relationship between lifelong alcoholism 
and anxiety disorders, and found anxious people believe they drink to relieve symptoms 
of nervousness or sadness. Regardless, there was insignificant evidence supporting the 
contention that depression or anxiety disorders are the usual cause of alcoholism.  
Researchers have concluded that high rates of comorbidity for anxiety and alcoholism 
may reflect a link between anxiety disorders and temporary substance-induced anxiety 
syndromes that are generally mild to moderate rather than severe (Schuckit & 
Hesselbrock, 1994). In the fourth and final model, bidirectional models have not been 
systematically examined. The bi-directional model proposes that having one disorder 
  4 
increases the vulnerability to other disorders. Despite the fifteen years of research, and 
model formation,  little is known about the etiology and temporal ordering of co-
occurring disorders and for this reason researchers and clinicians should consider all 
disorders as primary and treat them as such (Ridgely, et al, 1987; Minkoff, 1991; Drake, 
McLaughlin et al., 1991; Osher and Kofoed, 1989).   
 
Statement of the Problem 
 It was not until the early 1980s that a population of “young adult chronic patients” 
attempting to cope with mental illnesses and drug abuse disorders in their communities 
came to clinical researchers’ attention (Drake & Wallach, 2000). In the late 1980s, social 
researchers began to investigate assessment and treatment approaches for persons with 
co-occurring disorders. During this time, observers realized administrative, financial, 
organizational and clinical barriers this population encountered when seeking services for 
both their mental health and drug abuse disorders. 
 Between 1986 -1990 Hospital and Community Psychiatry published a number of 
research articles on the growing numbers of homeless persons with mental illness (Roth 
& Bean, 1986: Morrissey & Levine, 1987), public concern about violence associated with 
mental illnesses (Fisher, 1988; Swanson, et al, 1990), incarcerations of persons with 
psychiatric disorders (Jamelka, et al, 1989; McFarland, et al, 1989), high utilization of 
services and costs for chronic mental illnesses (Surber, et al, 1987; Surles, & McGurrin, 
1987), treatment non-compliance (Green, 1988; Corrigan, et al, 1990), and the risk of 
HIV infection in the seriously mental ill population (Cournos, et al, 1989: Lauer-Listhaus 
& Watterson, 1988). Surprisingly, there was no discussion on the interactions between 
problems nor was the role of substance abuse ever mentioned or explored. 
 It was not until the mid 1990’s that researchers studied the links between 
substance abuse and mental health disorders. Literature and research began to address the 
necessity for public funds to combat substance abuse by persons receiving disability 
payments (Rosenheck, 1997), to examine the role of trauma in the lives of individuals 
with co-occurring disorders (Goodman, et al, 1997), and to better understand the 
relationship between co-occurring disorders and serious infectious diseases (Rosenberg, 
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2001).  Such studies revealed the lack of a national healthcare infrastructure capable of 
prevention, diagnosis, and treatment of co-occurring disorders. Today researchers, 
practitioners and advocates are asking the question “How do we develop a plan for an 
optimal system of care and connect the dots from the current system to the desired 
system?”(Levin, Petrila, & Hennessy, 2004). In summary, consumers with co-occurring 
disorders are challenging our current delivery system, not only with their diverse service 
needs, public health concerns, high utilization and associated costs but moreover, forcing 
the treatment industry and governmental funding sources to identify and implement 
efficacious prevention and treatment strategies.    
   
Significance of the Study 
 The purpose of the study is to address a significant void in knowledge on the 
heterogeneity of co-occurring disorders and the effect these differences have on 
treatment. The long-term objective of the research study is to identify subgroups within a 
targeted outpatient population based on their distinctiveness from one another toward the 
eventual goal of predicting utilization needs, outcomes and costs as well as matching 
consumer needs with appropriate treatment approaches. Although, many treatment 
programs claim to individualize interventions, most do not.  The latter is most likely due 
to the scarcity of empirically-derived research, and the integration of research knowledge 
into practice. To effectively treat heterogeneous populations, researchers must identify 
empirically-derived homogeneous groups based on multiple determinants including, 
biological, behavioral, developmental, psychosocial, symptom severity and level of care 
needed. Subgroups identified in this research are not intended to depict classifications of 
consumers, rather; they display the universe of individual constellations with co-
occurring disorders (Minkoff, 2001).   
 The overarching goal of this research is to identify homogenous subgroups with 
co-occurring disorders for the purpose of exploring existing managed care strategies to 
determine if such strategies could benefit the advancement of treating co-occurring 
disorders.  Identification of subgroups will provide a mechanism to better understand the 
interrelationships between determinants that contribute to the etiology and problem 
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severity at an individual and group level. Secondly, in an effort to improve service 
delivery, empirically-derived subgroups hold important clinical implications for 
treatment models. In fact, the poor treatment outcomes consistently reported in literature 
for individuals with co-occurring disorders, may have more to do with the goodness of fit 
between the person and the treatment approach rather than the population itself.  Studies, 
such as this, can provide a theoretical basis and background information from which to 
improve our understanding of how best to serve heterogeneous populations. Finally, the 
conceptual framework behind identifying mutually exclusive subgroups, like those found 
in managed care, are based  on the premise that the level of resources necessary for 
delivering quality care is directly correlated with knowing and understanding the multiple 
domains of an illness or disorder. 
 
Research Questions 
 The literature suggests that individuals with co-occurring disorders differ greatly 
in symptomology, problem severity, service utilization, and level of functioning. 
However, the heterogeneity of this population has not been explored based on their 
unobserved distinctiveness from one another. Thus, the present study is exploratory and 
is designed to answer questions relating to the heterogeneity of co-occurring disorders for 
the purpose of identifying homogeneous subgroups and the clinical utility of such groups 
on treatment planning.  This study will provide possible answers to the following 
principle research questions: 
 1. Do homogenous subgroups exist in the sample of adult individuals entering an 
 outpatient program for co-occurring disorders? 
2. How many homogeneous subgroups exist? 
3. How well does the model fit the data? 
4. What are the size and nature of the homogeneous subgroups? 
5. What are the psychosocial variables associated with subgroup membership? 
6. If no subgroups exist, what other research attempts should be made to explore  
 the heterogeneity of co-occurring disorders. 
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Study Limitations 
 The central limitation of the present study is the use of retrospective data that was 
collected and recorded for reasons other than for the present research objectives. One 
issue resides in the sampling distribution during the original grant. Intake staff 
determined, through appropriate assessment procedures, if an individual would be better 
served by a community-based program, a residential program or a community-based 
program with case management. The purposive sampling technique could have been 
biased by staff’s decision on most appropriate locus of care. Such sampling bias in the 
original study could potentially effect the identification and number of subgroups by 
overrepresentation. The number of subgroups may be reduced because the sampling 
process may have inadvertently pre-determined homogeneous characteristics as part of 
program selection or assignment. Since the present study is examining the heterogeneity 
of a sample entering a community-based program, within group differences may be 
underrepresented. Such sampling errors may present a threat to the internal validity of the 
study and cause the sample not to be representative of the larger population. Thus, 
generalization of the findings for the present study cannot be assumed. 
 Another weakness of the current study is the researcher will not re-examine 
participant’s co-occurring disorders to eliminate diagnostic uncertainty. Multiple 
diagnoses for an individual are a major concern among clinicians for the reason that 
symptoms seen in the early stages of psychotic disorders are often times unclear and 
result in misdiagnosis (Shaner, 1999). Shaner studied diagnostic uncertainty in a cohort 
of cocaine abusers with chronic psychosis. A baseline assessment of 165 males, 
presenting for re-hospitalization, was diagnosed as having co-occurring disorders. The 
same cohort was re-assessed 18 months later using the same measurement instruments. 
At the end of the study, researchers were able to make definitive diagnosis in only 25% 
(41) of the cases.   
 Diagnoses of co-occurring disorders are especially problematic when patients 
present for treatment with psychological symptoms and when asked about substance use, 
the patient often times under report their use. Literature suggests that abuse of stimulants 
and amphetamines can cause psychiatric symptoms that resemble schizophrenia among 
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patients without a history of psychosis (Satel, Southwick & Gawin, 1991; Sherer, 1988). 
Because co-occurring disorders can cause a wide range of psychosocial symptoms, the 
clinician may misdiagnose a consumer with either a false positive or a false negative 
diagnosis of schizophrenia. Misdiagnosis leads to mistreatment, inappropriately 
prolonged use of antipsychotic medication or a failure to prescribe necessary medication 
(Shaner, Roberts, Eckman, Racenstein, Tucker, Tsuang, & Mintz, 1998). Uncertainty of 
diagnosis may be a contributing factor as to why many of consumers are non-compliant 
with treatment and medication programs. For the current study, a high rate of 
misdiagnosis among the sample population could seriously render the results unreliable if 
strict protocols are not adhered to during the initial clinical assessment. 
  
Definition of Terms 
Co-occurring Disorders/Dual Diagnosis 
 In the mid 1980’s there was an increase and attention to individuals reporting the 
co-occurrence of a mental health and alcohol or drug problem (SAMHSA). The term co-
occurring disorders have been referred to over the years as, mentally ill chemically 
addicted (MICA); chemically abusing mentally ill (CAMI); mentally ill substance abuser 
(MISA); substance abusing mentally ill (SAMI); mentally ill chemically dependent 
(MICD); co-occurring addictive and mental disorders (COAMD); individuals with co-
occurring psychiatric and substance disorders (ICOPSD); addiction and co-occurring 
disorders (ACD); dually disordered and dually diagnosed. Recent literature utilizes the 
term dual diagnosis most frequently. However, Drake and Wallach (2000a), argue that 
this term is an "unfortunate misnomer” and the term tends to overlook the board range of 
psychosocial issues associated with “multiple interacting disorders and disadvantages.” 
Throughout the paper, co-occurring disorders will be defined in accordance with 
Substance Abuse and Mental Health Service Administration’s (SAMHSA) revised 
Treatment Protocol (TIP). According to SAMHSA, people with co-occurring disorders 
are. 
 “individuals who have at least one mental disorder as well as an alcohol  
 or drug use disorder. While these disorders may interact differently in  
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 any one person (e.g., an episode of depression may trigger a relapse into  
 alcohol abuse, or cocaine use may exacerbate schizophrenic symptoms),  
 at least one disorder of each type can be diagnosed independently of the other.  
  
Co-occurring disorders vary between individuals depending on the severity, chronicity 
and degree of impairment in functioning (CSAT, 1994).  There is no single combination 
of substance abuse and mental health that constitutes co-occurring disorders but rather a 
wide variability of disorders and symptoms that are commonplace in this population. 
 
Consumer versus Client/Patient 
 Terminology is diverse when referring to users of mental health services and is 
largely contextually determined.  Historically, sociologists have had concern with 
professional-client relationships, particularly the doctor-consumer relationship (Freidson, 
1961; Bloom, 1963; and Wilson, 1963). Bloom (1963) and Wilson (1963) suggest the 
consumer-professional relationship is constructed on the assumption that patients take on 
a passive role and are denied the power and freedom to participate in treatment decisions. 
In a recent study conducted by Sharma, Whitney, Kazarian, and Manchanda (2000), 
proponents of the patient paradigm, considered the term to appropriately imply the need 
for psychiatric services or medical care. These same proponents prefer the term patient 
rather than client or consumer because such terms imply human interaction in a business 
context rather than a healing context. Whereas, opponents argue the term patient, implies 
stigmas associated with sickness, disabilities, authoritarianism, and paternalism (Sharma, 
2000). 
 A 1994 U.S. study of preferred terms for users of mental health services revealed 
a growing tendency of replacing the term patient with client (Sharma, et al. 2000). 
Proponents of the client paradigm suggest the term connotes a less passive, more 
collaborative relationship between service providers and service users. Over the last five 
years the term client has been replaced by consumer in funding arenas, such as 
SAMHSA, for co-occurring disorders. As well, under the paradigm of managed care, the 
term consumer is used most often when describing the various populations seeking 
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mental health and substance abuse treatment For the purpose of this paper, the term 
consumer will be used in place of client or patient in support of moving client-
practitioner relationships to consumer-provider social relationships that accelerate the 
ombudsman format to mediate differences between consumers (purchasers of services)  
and service providers (health care professionals).  
 
Managed Care 
 Managed care is an overarching concept that combines methods of organizing 
health care service delivery and reimbursement. A common business strategy in managed 
care is to maximize outcomes at the lowest possible cost. The term managed care holds 
multiple meanings to different audiences. The American Medical Association 
(AMA)defines managed care as "those processes or techniques used by any entity that 
delivers, administers and/or assumes risk for health care services in order to control or 
influence the quality, accessibility, utilization or costs and prices or outcomes of such 
services provided to a defined enrollee population" (Bazelon Center, 2000).  The Health 
Insurance Association of America defines managed care as "systems that integrate the 
financing and delivery of appropriate health care services to covered individuals through 
the use of four elements: arrangements with selected providers to furnish a defined set of 
health care services to members; explicit standards for choosing those providers; formal 
programs for ongoing quality assurance and utilization review; and significant financial 
incentives for members to use the plan's providers and procedures" (Bazelon Center, 
2000). 
 
Acute Care 
 The American Medical Association (AMA) defines the term acute care as a 
pattern of health care in which a consumer is treated for an acute (immediate and severe) 
episode of illness, for the subsequent treatment of injuries related to an accident or other 
trauma, or during recovery from surgery (Bazelon Center, 2000). Specialized personnel 
using complex and sophisticated technical equipment and materials usually give acute 
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care in a hospital. Unlike chronic care, acute care is often necessary for only a short time 
(Kongstvedt, 1996). 
 
Burden of Illness 
 The burden of illness refers to the total consequences associated with an illness or 
disorder across all stakeholders. Wells, Miranda, and Gonzalez (2002) defines 
stakeholders as consumers and their families, health care providers, payers and society 
and defines consequences as reduced health status, quality of life, costs of care, and 
social consequences. The American Medical Association (AMA) suggest the term burden 
of illness typically includes: incidence and prevalence of the disease by severity; impact 
of the disease on clinical and other health outcomes, including quality of life, functional 
status, and productivity; impact of the disease on medical resource utilization and cost; 
and other individual, family, and societal impacts.  
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CHAPTER II 
REVIEW OF THE LITERATURE 
 
Introduction 
 Over the past 20 years researchers and health care practitioners have come to 
realize, in addition to high prevalence rates, individuals with co-occurring disorders did 
not represent a homogeneous group. Treatment offered to one consumer would not 
necessarily be appropriate for another consumer. As the concept of dual diagnoses 
evolved, treatment facilities began to understand the need to re-address existing treatment 
programs that had been traditionally separated between substance abuse and mental 
health services. In the late 1980’s the National Institute for Mental Health (NIMH) 
recommended that all co-occurring disorders be treated concurrently. As a result, 
initially, three treatment approaches were identified and implemented: sequential, parallel 
and integrated model of treatment. 
 With the growth of managed care and its cost containment philosophy, integrated 
treatment programs were seen as a way, in the 1990’s, to hold down rising healthcare cost 
and improve the quality of care associated with mental health and substance abuse 
treatment services.  Despite original efforts to improve quality of care and reduce cost, 
managed care gained a reputation for managing costs and benefits rather than patient care 
(Robinson, et al. 2004). In the following sections, there will be a discussion on the 
emergence and impact of managed care on substance abuse and mental health systems.  
 As managed care becomes a permanent part of social service delivery landscape 
in the United States, social researchers and clinicians must place a greater emphasis on 
chronic behavioral care versus acute care models (Berkman, 1996; Keigher, 1995; 
Rosenberg, 1998; Rosenberg & Holden, 1997). Furthermore, by thoroughly 
understanding the limitations and benefits of managed care, the more likely managed care 
initiatives will not become yet another problem in providing care for co-occurring 
disorders. When considering new treatment modalities for co-occurring disorders within 
a behavioral health system, it is beneficial to compare similar populations and their 
treatment under existing managed care programs. Three overarching managed care 
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strategies, used in three predictive models, will be explored for clinical utility in treating 
co-occurring disorders. 
  It is essential to consider the heterogeneity of co-occurring disorders when 
considering new treatment modalities. Thus, it becomes pivotal to identify these 
differences for treatment approaches and goals. Research shows that heterogeneity of 
treatment populations can be reduced through empirically-derived homogeneous groups 
based on multivariate analysis.    
 
Treatment Modalities for Co-Occurring Disorders 
 During the past two decades, the challenge has been providing effective treatment 
to individuals with co-occurring psychiatric and substance disorders. From an economic 
perspective this consumer group has significantly higher overall health and societal costs 
than those with a single disorder (Hoff & Rosenheck, 1998; 1999).  From a health care 
provider viewpoint, dually diagnosed consumers present a unique challenge for clinical 
staff and administrators because they are generally experienced as “system misfits” at 
every level of the service system (Minkoff, 2003). Minkoff suggests that clinicians and 
administrators contort individuals with co-occurring disorders to fit traditional 
interventions, as well as contorting their skills to treat consumers either as a mental health 
or substance abuse clinician but not both. Substance Abuse and Mental Health Service 
Administration (SAMHSA) identified variations in treatment models and approaches 
unnecessarily create barriers to recovery and required consumers to navigate through a 
complicated and often contradictory treatment system.  
 This following section will examine the long tradition of separate mental health 
and substance abuse systems and how these two systems have failed in providing a 
comprehensive treatment approach. However, an increasing number of evidence-based 
interventions and programs have demonstrated the efficacy of an integrated treatment 
approach that combines methods and skills derived from both psychiatric and addiction 
treatment practices to treat co-occurring disorders in a single setting, with a single staff 
(Drake, et al 1997; Ho et al. 1999; Minkoff 1989; Osher, 1996). 
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Sequential Treatment Approach 
 Historically, the first treatment approach for this complex population was 
considered sequential.  Consumers were treated by one system (addiction or mental 
illness) and then the other, depending upon prioritization of disorders. Consumers 
enrolled in this treatment approach frequently received conflicting therapeutic messages 
from separate systems. Compounding this system fragmentation, consumers were likely 
to bounce back and forth between mental health and substance abuse service systems all 
the while increasing their risk for other serious medical problems, suicide, 
criminalization, unemployment, homelessness, and separation from families and 
communities. Additionally, differences in insurance coverage and in funding mechanisms 
between the two systems continued to fuel system disconnect (Minkoff, 2000). 
 
Parallel Treatment Approach 
 The second treatment model and the standard of treatment for decades, for co-
occurring disorders, is a simultaneous (parallel) treatment approach providing consumers 
with both mental health and addiction treatment. The consumer receives separate mental 
health and substance abuse services from two separate agencies. Typically, parallel 
treatment does not provide coordination of care between the two systems and inevitably 
burdens the consumer to navigate themselves through non-responsive and fragmented 
systems (Drake, et al, 1996).   SAMHSA’s Report to Congress (2000) found that 
providers of parallel care often proposed activities or goals that contradicted or were 
incompatible with those of the other. Other treatment problems cited by the SAMHSA 
report were the contraindications associated with two very different pharmacological 
treatment philosophies.    
 
Research Literature Review 
 Both sequential and parallel treatment models have serious limitations for optimal 
treatment for co-occurring disorders, compounded by low program retention rates (Drake, 
et al, 1996). Ries (1993) points out the chief concerns with sequential and parallel 
treatment approaches are that they promote fragmentation of services and failures of 
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referral and coordination of care. Early research on the course of co-occurring disorders, 
consumers receiving traditional sequential and parallel services showed increased rates of 
hospitalizations over a 1 year period for psychiatric symptoms (Drake, et al, 1989; Osher 
et al. 1994). Longitudinal research on the earlier treatment approaches indicated a very 
slow rate of recovery, with usually less than 5 percent becoming abstinent each year 
(Mueser, et al. 1997).   
 
Integrated Treatment Approach 
 As a result of the service gaps, poor outcomes, and redundancy in treating co-
occurring disorders, administrators, clinicians, researchers, and consumers realized the 
need for an integrated care system where mental health and substance abuse treatment are 
provided by the same clinician or group of clinicians (Drake, et al. 1995; Mueser, et al. 
1997). SAMHSA (2000) currently endorses an integrated treatment model for co-
occurring disorders that provides a unified and comprehensive treatment program for the 
consumer. Both disorders are treated as primary and consumers receive simultaneous 
treatment under one roof. All services are typically provided through a multidisciplinary 
team that has received specialized training in co-occurring disorders. An integrated 
treatment approach alleviates consumer’s responsibility for coordinating their own care 
and transfers that responsibility back to the professionals. 
   Critical components of an integrated program have been outlined (Minkoff, 
1991; Drake, et al, 2001) and include staged interventions; assertive outreach, 
motivational interventions; simultaneous interventions; risk reduction; tailored mental 
health treatment; tailored substance abuse treatment; counseling; social support 
interventions; comprehensiveness; a long-term perspective of remission and recovery; 
and cultural sensitivity and competence. Ideally, integrated programs combine and build 
upon existing programs wherever possible. Despite, federal and local government 
awareness, many communities lack the range of services, specialized staffing resources 
and funding to offer a continuum of care approach which is embedded in an integrated 
treatment approach. 
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 Research Literature Review 
 Integrated treatments are touted as being more effective than parallel or sequential 
mental health and substance abuse treatments delivered in separate settings or by separate 
programs (Drake, 2001), and by contrast, evidence continues to demonstrate that 
individuals who receive non-integrated services have poorer outcomes (Hoff, 1999). In 
the 2002 Report to Congress, integrated treatment was said to be successful in reducing 
substance abuse disorders, and symptoms of mental disorders (pg. 6). Prior to the Report 
to Congress (2002), Drake and colleagues (1998) studied the effectiveness of integrated 
treatment by reviewing 36 research studies. In determining the “comprehensiveness” of 
the programs each had to have at least three of the aforementioned components. A cross 
section of the 36 studies conducted by Drake and colleagues has been chosen for further 
review and discussion. 
 Between 1993 and 1997, five pretest-posttest open trails with follow-up intervals 
ranging from 18 months to seven years reported variable improvement in rates of 
hospitalization and severity of substance use   (Durrel, et al, 1993; Meisler, et al, 1997; 
Drake, et al, 1993; Bartels, et al, 1996; Godley, et al, 1994). Durrel and colleagues (1993) 
reported 66 percent of their chronically mental ill participants had significantly reduced 
their substance use at 18 months. The other studies reported that 41 to 61 percent of their 
subjects had reduction in their substance use. Mueser’s (1997) study also stressed an 
improvement in housing outcomes. In the pilot study executed by Drake, et al (1993), 18 
schizophrenic outpatients’ diagnosed with alcohol dependency achieved a stable 
remission from alcoholism (61.1%) with a mean duration of remission at 26.5 months. 
Godley and associates ((1994) demonstrated a reduction in substance use and 
hospitalizations. 
 Two quasi-experimental studies compared integrated treatment with non-
integrated treatment (Drake, et al, 1997; Drake, Mercer-McFadden, et al, 1998) 
outcomes. Data for outcomes were taken from an 18-month follow-up interview for 158 
homeless, seriously mentally ill addicted subjects and compared with those of 59 similar 
subjects receiving parallel treatment services. The integrated treatment group spent 
significantly more days in a stable housing arrangement and less time in an institutional 
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setting than those in the parallel treatment. Additionally, those in the integrated program 
achieved significantly greater improvement in alcohol abuse at follow-up than those in 
the parallel group. 
 Other studies comparing integrated treatment with other forms of treatment for 
co-occurring disorders generally support the proposition that integrated treatment has a 
positive effect on individuals across a number of different types of outcome measures 
(e.g., substance abuse, psychopathology and general functioning) (Drake et al., 1998, 
Jerrell & Ridgely 1995a; Carroll & McGinley 1998; French et al., 1999; Jerrell & 
Ridgely, 1995b; Barrowclough et al., 2001).  The majority of studies on integrated 
treatment have been directed toward outpatient subjects, with positive, outcomes 
(Barrowclough, et al, 2001; Carmichael, et al, 1998; Drake, et al, 1998; Drake, et al, 
1997; Godley, et al, 1994; Jerrell & Ridgley, 1995). However, only a few of these studies 
have found statistically significant effects (Greenberg, 2002). Mueser (1997) suggest 
many of these studies have provided a reason for “cautious optimism” in part due to 
small samples and the fact that most of the participants were homeless (RachBeisel, 
1999).  
 Two randomized controlled trials have recently demonstrated that an integrated 
treatment approach was effective in producing positive benefits on a number of outcomes 
(Haddock, Barrowclough, Moring, Tarrier, & Lewis, 2002; Bartels, Coakley, Zubritsky, 
Ware, Miles, Arean, Chen, Oslin, Liorente, Costantino, Quijano, McIntyre, Linkins, 
Oxamn, Maxwell, & Levoff, 2004). In the multisite randomized trail, researchers sought 
to determine if integrated treatment improved program engagement compared to an 
enhanced referral service to mental health/substance abuse service providers by a primary 
care physician (Bartels, et al. 2004). Results indicated 71% of consumers in the integrated 
model remained engaged in services compared to 49% in the enhanced referral model.  
Overall results suggest that integrated service arrangements improve engagement and 
access to mental health and substance abuse services when compared to an enhance 
referral program.   
 Despite the support that integrated treatment is the method of choice for 
intervention of co-occurring disorders, according to SAMHSA (2003) there is a lack of 
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strong evidence for which kinds of integrated interventions work the best. Furthermore, 
with the advent of managed care and its focus on cost-containment and quality, few 
managed care initiatives have been implemented to standardize integrated programmatic 
interventions or cost structures to address poor clinical outcomes and rising health care 
cost associated with co-occurring disorders (Minkoff & Regner, 1999). 
 
The Emergence of MBHOs 
 Managed health care is a nebulous concept which in theory represents a system of 
health care delivery that attempts to manage the cost of health care, the quality of that 
health care, and access to that care. SAMHSA touts managed care as an opportunity to 
solve many of the problems of co-occurring disorders by examining its common 
administrative structure such as non-categorical funding, clinical review of treatment 
plans based on a criteria which defines appropriate care, improved access to public 
services, performance standards, and data collection and dissemination, (Ridgely, 1997).  
Due partially to managed care local, state, and federal governments are discussing parity 
of benefits and the need to promote collaboration between funding streams and healthcare 
providers.  
 To better manage cost and quality, managed care organizations (MCO’s) created a 
bifurcated delivery system by separating physical health from behavioral health through 
the use of specialized provider contracts. These specialize contracts, also known as carve 
outs, had mixed results. Under the new framework, mental health and substance abuse 
providers formed managed behavioral health organizations (MBHO’s). The new 
MBHO’s reimbursement structures were based on risk-sharing contracts as opposed to 
fee-for-service models seen prior to manage care. As MBHO’s evolved, financial 
incentives through risk sharing contracts shifted the risk of health care cost to the MBHO, 
creating the incentive to reduce cost by aggressively managing care (Sturn & Roland, 
1999).  However, many of these providers and the healthcare industry at large were 
unprepared for the major clinical, economic and systems impact from this population. 
Consumers with co-occurring disorders had higher rates of relapse; rehospitalization; 
poor program retention; high emergency room visits; noncompliance with treatment and 
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medications; increased criminal behavior; homelessness; and decreasing daily 
functioning capabilities. Another growing concern with the separation between physical 
health and behavioral health systems is that behavioral health care systems continue to 
function under an acute care model used by physical health systems. This point will be 
discussed in greater detail throughout the paper. 
 
The Impact of MBHOs on Service Delivery 
 A critical concern with placing MBHO’s at risk, when individuals with complex 
clinical needs are enrolled in programs designed on acute models of care, is the provider 
often times had to reduce cost by eliminating services or staffing resources (Robinson, et 
al. 2004). A study assessing the impact of behavioral managed care from 1988 to 1998, 
found a disproportionate decline in behavioral health benefits (54.7%) when compared to 
physical healthcare benefits (11.5%)(Hay Group, 1999). In the same report, the Hay 
Group found MBHO’s imposing limitations on inpatient psychiatric care and annual visit 
limits on outpatient care.  In another study of residential substance abuse programs, the 
researchers found a decline in number of days in treatment per episode down from 32.1 
days in 1988 to 22.5 in 2001, while the average number of annual inpatient admissions 
rose from 834.7 in 1988 to over 1,033 in 2001 (McMaster, Holleran, Chantus & Kostyk, 
2005). The results of a 2002 national survey of substance abuse treatment services that 
offered programs for co-occurring disorders, determined there was a slight increase in 
services, if at all, from 1997 (48%) to 2002 (49%) (McFarland & Garbiel, 2004).  The 
impact of declining benefits and governmental funding has raised concern that services 
may be reduced below desirable levels of care. 
 
MBHOs in the Public Sector 
 With the emergence of public managed care for mental health and substance 
abuse treatment programs, states are being challenged to stretch scarce public funds. 
Unlike the private sector, public mental health and substance abuse funding is 
disproportionate when compared to public expenditures for the same treatment. Public 
sector services receive government funding that tends to target sub-populations (mental 
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illness or substance abuse), making it difficult for community programs to serve a 
broader and more diverse population. As a result local community service providers are 
forced to accept categorical funding targeted for specific individuals or for a specific type 
of treatment. As public payers struggle with diminishing budgets, quality of care is 
jeopardized for public consumers, who are relatively powerless to voice their concerns or 
influence policy or funding decisions. 
 Managed care initiatives have been adopted by some states’ largely in response to 
scarce resources and the high prevalence rate of co-occurring disorders among Medicaid 
and Supplemental Security Income (SSI) beneficiaries (Bachman, et al. 2004). As a 
result, the population reporting comorbidity seeking public sector services is significantly 
greater than the population served by private plans. Furthermore, most public programs 
are designed around an acute care model, and are not organized to respond to co-
occurring disorders. The public mental health system tends to treat individuals with 
severe and chronic mental health such as schizophrenia, bipolar disorders, major 
depression, and borderline personalities (Bazelon, 2000). Typically, the system is unable 
to address substance abuse issues that are concurrent with the individual’s mental health 
status. On the other hand, substance abuse treatment systems are equally unprepared to 
respond appropriately to mood, anxiety or personality disorders.  
 
Managed Care Initiatives for Co-occurring Disorders 
 In 1995, SAMHSA sponsored the Managed Care Initiative project by creating a 
policy and research panel of national experts, consumers, and advocacy members 
responsible for conducting a literature review. The panel was accountable for developing 
an annotated bibliography (Managed Care Initiative Panel, 1997) of all published and 
unpublished material relating to co-occurring treatment. In 1998, the panel reported there 
were no standards of care for treating co-occurring disorders in any healthcare system. 
  In 2000 Congress called upon SAMHSA and the Department of Health and 
Human Services (DHHS) to prepare a report outlining the scope of the issues surrounding 
the prevalence and treatment of co-occurring disorders.  SAMHSA developed a National 
Advisory Council Subcommittee on Co-occurring Disorders consisting of content 
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experts: State mental health and substance abuse authorities, researchers, and advocates 
to offer research, data, and editorial comments. Additional guidance and opinions were 
solicited from experts in related fields, including homelessness, housing, criminal justice, 
social services, education, aging, primary care, public and private hospitals, and health 
plans. The end result was a “Blueprint for Action” addressing co-occurring disorders and 
all the attendant issues and barriers to access. 
 As new knowledge surfaced about co-occurring disorders, leading experts 
denounced the notion there was a single correct intervention and it was MCO’s (both 
private and public) responsibility to individualize treatment by discrete levels of care for 
each consumer (Minkoff, 2000).  From this national discussion, SAMHSA has endorsed 
managed care initiatives advocating for integrated care, a focus on cost effectiveness and 
efficient utilization of scarce resources designed to improve the quality and outcome of 
care for co-occurring disorders (see Appendix B) 
 
Overarching Strategies and Initiatives 
Little research has been conducted on the impact of managed care on behavioral 
health services (Carlson, Gabriel, Deck, Laws, & Ambrosio, 2003) and less is known 
about the impact of managed care initiatives on co-occurring disorders (Bachman, 
Drainoni, & Tobias, 2004). Regardless, there is wide agreement among experts and 
policymakers that managed care initiatives will facilitate service integration and 
continuity of care (Minkoff, 1997).  As managed care experienced higher utilization and 
cost from complex populations, it was forced to re-examine its acute care model based on 
episodic care. By shifting focus from a treatment approach that was driven by intensity of 
services (acute care); to a strategy rooted in continuity of care with a long term 
perspective towards individualized treatment has proven to be both cost effective and 
efficacious in primary healthcare settings.   
The purpose of this section is threefold. First and most obviously, this section 
explores the utility and research literature of three overarching managed care strategies 
used to control and manage quality, service utilization and cost for chronic illnesses.    
Secondly, this section supports the notion that managed care strategies developed for 
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chronic illnesses in a primary care setting can be beneficial in treating co-occurring 
disorders. Lastly and least obvious, the section will begin to build on a new conceptual 
framework for how classifications or subgroups of co-occurring disorders can facilitate 
treatment planning. Studies conducted on the three different strategies were selected 
based on research designs that utilized predictive models that accounted for between-
group differences rather than explicitly comparing one group to another. Such differences 
will be used later to discuss treatment implications for co-occurring disorders.    
 
Adjusted Clinical Groups – ACGs 
Currently, MCO’s uses a series of mutually exclusive health status categories, for 
determining medical care plans and cost. The Johns Hopkins University of Hygiene and 
Public Health Center created these health status categories to examine the relationship 
between morbidity or burden of illness and health care services utilization among 
children in managed care settings. These health status categories are defined by morbidity 
(rate of incidence of disease), age, and gender and referred to in managed care as adjusted 
clinical groups (ACGs). ACGs are based on the premise that the level of resources 
necessary for delivering quality care to a given population is correlated with the illness 
burden (the rate in which an illness/disorder negatively affects multiple domains) of that 
population. Originally ACGs were designed to predict ambulatory care visits over a one-
year period, but expanded to incorporate the prediction of total medical resources 
necessary over a specific period of time. MCO’s have employed ACGs since the mid 
1980’s in predicting populations past and future health care utilization and cost.  The 
conceptual framework behind ACGs is that the illness burden is a better predictor of 
needed health service resources than the presence of a specific disease or diagnosis (e. g., 
co-occurring disorders).  
 
Research Literature Review 
 A recent study assessed the predictive accuracy of ACGs within Medicaid and 
poverty related populations in Mississippi, Georgia, and California. (Adams, Bronstein, 
& Raskind-Hood, 2002). The investigators utilized split-sample method to compare two 
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non-random groups (high cost versus located in urban poor areas) to assess the efficacy 
of ACGs predictive accuracy. Data for the analysis was taken from the states 1994 
Medicaid enrollment and claims data for Georgia and Mississippi. All enrolled 
individuals were included in Georgia and Mississippi. Due to the large enrollment in 
California’s Medi-Cal program, data were collected from seven rural and urban counties, 
representing approximately 58 percent of the state’s enrollees. Individuals over the age of 
65 were excluded since they are often excluded in States’ Medicaid managed care 
programs. Data extracted from claim information included diagnosis, procedure codes, 
and medical expenditures. Findings indicated ACGs improved predictive accuracy for 
high cost conditions in all three states, but only improved predictive accuracy in 
Georgia’s poorest urban areas. A limitation of the study was in part due to Mississippi’s 
and California’s high proportion of short term enrollees. Short term enrollees represent 
higher costs (Schwalbert, 1997) due to the lack of adequate information on health risks 
over a significant time period (Adams, et al. 2002).   
 Another study examined the validity and feasibility of applying ACGs to a 
veteran population (Greaney & Ciesco, 2000). The investigators concluded that ACGs 
significantly predicted the level of resources and cost necessary to treat a veteran 
population with high proportions of multiple medical and psychiatric comorbidities. In an 
earlier study conducted by Fowler & Anderson (1996), ACGs were responsible for 
increasing the ratio of payments (expected capitation expenditures) for 70 percent of 
Medicaid children with chronic health conditions. 
 Accounting for the illness burden of a population, health care providers are more 
likely to receive adequate payment for recipients of public managed care, and public 
health consumers are more likely to receive the wrap-around, comprehensive care they 
need. Replicating strategies associated with ACGs would enable public managed 
behavioral care systems to prospectively identify and co-ordinate care for consumers with   
multi-dimensional health care needs  
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Disease Management 
 Chronic co-occurring disorders often resemble the course and pattern of chronic 
physical conditions, such as diabetes, coronary heart disease, asthma, or arthritis (Boyle, 
White, Loveland, Godley, Corrigan, and Hagen, 2000; Cousins & Liu, 2003). Managed 
care has addressed long term care for chronic physical conditions through the application 
of disease management. The Disease Management Association of America (DMAA) 
defines disease management as a “system of coordinated health care interventions and 
communications for populations with conditions in which consumers self-care efforts are 
significant.” As we will learn later, self-care and motivation to change are key principles 
in treating co-occurring disorders. Key treatment principles of disease management are 
the use of multidisciplinary teams over a long history of care involving consumers and 
their families (Boyle, 2000). Many of these concepts are represented in recent managed 
care initiatives for treating co-occurring disorders (see Appendix B). 
  
Research Literature Review 
 Despite the growing recognition and acceptance of the disease management 
concept in primary health care settings, behavioral health care is prone to use an acute 
medical model paradigm to treat chronic co-occurring disorders (Boyle, et al. 2000).  In 
1996, nearly 54 percent ($42.7 of $79.3 billion) of national expenditures for behavioral 
health care were spent on short-term inpatient treatment, residential treatment, medical 
acute care treatment, or nursing home care (Mark, et al. 1998). Acute care models 
exemplify short-term treatment approaches responsible for under treatment of co-
occurring disorders that often exacerbate symptoms, and perpetuates fragmented 
treatment (Minkoff, 2000). 
 Disease management programs have shown success in the management of chronic 
conditions characterized by a high prevalence and expense factor, and the significant role 
that a consumer’s behavior can have on the progression of the condition (Cousins & Lui, 
2003).  A three-year study to assess the impact of a disease management program on 214 
participants concluded the program improved functional status and presented an 85 
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percent decrease in hospital admission rates compared to a control group (Fonarow, et al. 
1997).  
 In another research, Leveille, et al. (1998) conducted a randomized study to 
evaluate a 1-year, senior center-based chronic illness self-management and disability 
prevention program on health, functioning, and health care utilization with the intent to 
reduce disability risks and improve self-management of chronic illness in frail older 
people. The trail was in collaboration with two large MCO’s. Chronically ill adult seniors 
(N=201) aged 70 and older were recruited. Results indicate the intervention group 
showed fewer declines in function, as measured by disability days and lower self-
reported scores on a health assessment questionnaire. Reported hospitalizations decreased 
by 38 percent for the participants enrolled in the program and rose by 69 percent of those 
in the control group. The total number of inpatient hospital days during program 
enrollment was significantly less in the intervention group compared with the control 
group (total days = 33 vs. 116, P = .049). Participants enrolled in the program showed 
significantly higher levels of physical activity and senior center participation and 
significant reductions in the use of psychoactive medications.  
 In a similar study conducted by Lorig et al. (2001), 613 consumers were recruited 
from various Kaiser Permanente hospitals and clinics to participate in a disease self-
management program. Main outcome measures included health behavior, self-efficacy 
(confidence in ability to deal with health problems), health status, and health care 
utilization, assessed at baseline and at 12 months by self-administered questionnaires. At 
1 year, the program reported statistically significant improvements in health behaviors, 
self-efficacy, and health status and reported fewer emergency room visits than the control 
group.     
Disease management has shown promise in improving outcomes in a number of 
medical disorders, but this approach has received limited research in substance dependent 
individuals (McKay, Lynch, Shepard, Pettinati, 2005) and no such research has yet to be  
conducted on co-occurring disorders (Cousins, 2004). In spite of the evidence of 
chronicity, due to high relapse rates associated, with co-occurring disorders, most 
substance abuse programs are characterized by serial episodes of acute treatment with 
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aftercare programs limited to passive referrals to self help groups (Dennis, Scott, and 
Funk, 2003).  Substance abuse aftercare treatments and subsequent studies have focused 
on step down programs as forms of continuing care and have not focused on post-
discharge recovery management with the intent of monitoring self-care and early re-
intervention (Dennis, 2005).      
 
Consumer-Treatment Matching 
 Minkoff (2003) emphasizes the need to adopt disease management strategies for 
individuals with co-occurring disorders. Strategies discussed in disease management such 
as multidisciplinary teams, self-management and long-term care perspective, and ACG’s 
mutually exclusive health status categories, will assist in the development of practice 
guidelines that facilitate clinicians in appropriately matching consumer to treatment 
plans. With the arrival of managed care, clinicians, social workers, health care providers 
and medical care administrators are focused on the most cost-effective treatment 
approaches.  A proven cost effective approach is matching consumer characteristics to a 
treatment approach (Gastfriend & McLellan, 1997; Hser, et al, 1999; Longabaugh, et al, 
1994; Thronton, et al, 1998). For nearly two decades researchers have studied consumer-
treatment matching in order to identify factors that promote optimal treatment outcomes 
((Gastfriend & McLellan, 1997; McLellan, et al. 1983). These same researchers have 
identified two major placement strategies that have been routinely used: (1) match 
consumers to treatment modality, or (2) match consumers to level of care.     
 
Research Literature Review 
 As researchers and clinicians continue their quest for predictive utility of 
treatment approaches, we must consider the findings of Project MATCH (1996). Project 
MATCH was a multisite, randomized clinical trail that randomly assigned participants to 
one of three treatment settings; (1)Cognitive Behavioral Coping Skills Therapy (CBT), 
(2) Motivational Enhancement Therapy (MET), and (3) 12-Step Facilitation Therapy 
(SFT) for the purpose of determining whether patient-treatment matching improves 
outcomes. The original Project MATCH research group conducted two parallel but 
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independent clinical trials in three separate treatment settings (outpatient, aftercare and 
following a 3 month residential or day hospital treatment program). Subjects in all three 
settings demonstrated a decrease in frequency and volume of drinking (Project MATCH, 
1998). The Project MATCH research group reported few clinically significant outcome 
differences among the three treatments in either the outpatient or aftercare program 
(1998). Contrary to prediction, findings were essentially negative with regard to patient-
treatment matching (Glaser, 1999). However, findings did suggest psychiatric severity 
should be considered when assigning consumers to outpatient therapies (Project 
MATCH, 1998).  
 Subsequent analyses of the original Project MATCH assessed the benefit of 
matching alcohol dependent consumers to the same three treatment approaches and 
research design in the original Project MATCH. Outcome measures were percentage of 
days abstinent and drinks per day. Findings demonstrated significant posttreatment 
attributes by treatment interactions: (1) consumers rating high on anger and treated in 
MET had better post-treatment drinking than in CBT; (2) aftercare clients high in alcohol 
dependence had better post-treatment outcomes in TSF; low dependence consumers did 
better in CBT.   
 The results of the three year Project MATCH follow-up studied 952 consumers in 
a multisite clinical trial designed to test a priori consumer treatment matching hypotheses, 
that anger and dependence should be considered when assigning consumers to treatment. 
As predicted, consumers high in anger had better outcomes in MET than in CBT or SFT. 
Consumers high in anger treated in MET fared better on average abstinent days (76.4%), 
whereas their counterparts in CBT and SFT had on average less abstinent days (66%).  
Conversely, consumers rating low on anger fared better after treatment in CBT and TSF 
than in MET. In addition, reduction of drinking observed in year one post-treatment was 
sustained over a 3-year period.  
 Despite, the failure to find many significant matches between client 
characteristics and types of treatment settings, Project MATCH made a significant 
contribution to the way social researchers explain null results (Stockwell, 1999). Even 
though the general hypothesis that matching would improve treatment outcomes was not 
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confirmed, Project MATCH did reveal subtle matching effects that could have been lost 
in the main effect of treatment across all types of consumers (Stockwell, 1999). With this 
in mind, it is important to compare patient-treatment matching strategies to other areas of 
health and social care. Broader outcome measures with a research focus on patient-
treatment interaction effects rather than on treatment or patient main effects could 
improve the efficacy and effectiveness of service delivery (Godfrey, 1999).  
 A recent study evaluated a patient-treatment matching strategy for co-occurring 
disorders with the intent to examine whether or not matching resulted in better treatment 
outcomes at discharge and at a four-month follow-up (Timko & Sempel, 2004). The 
researchers hypothesized that patients’ with severe co-occurring disorders would have 
better treatment outcomes in service-intense hospital-based residential programs, 
compared to  those patients with less severe disorders receiving community-based 
residential services.  A sample of 230 veterans received a 10-point severity rating initial 
assessment used for treatment planning and program referral.  Participants were randomly 
assigned to one of four treatment groups based on symptom severity: high-severity/high 
intensity (n=63) or high-severity/low intensity (n=35), and moderate-severity/high 
intensity (n=47) or moderate-severity/low intensity (n=85). As predicted, matched 
patients had better overall outcomes than mismatched patients. High-severity participants 
in high-intensity programs had better outcomes than did high-severity patients in low-
intensity programs. Moderate-severity patients showed comparable outcomes between 
the high and low intensity programs.   
 
The Heterogeneity of Co-occurring Disorders 
 Despite the extensive attention and documentation of this phenomenon and how 
best to provide treatment for this population, most research has treated persons with co-
occurring disorders as a homogeneous population, while most clinicians continue to treat 
this population under traditional treatment approaches. Services are being provided on a 
“one size fits all” basis, ignoring the heterogeneity of individual’s with co-occurring 
disorders (SAMHSA, 2000). Yet, there is a growing consensus among researchers that 
the etiology for co-occurring disorders is best conceptualized in terms of multiple 
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determinants including biological, behavioral, developmental, and psychosocial factors 
(Hester & Miller, 1986). Several inpatient program studies have attempted to differentiate 
consumers with co-occurring disorders by assigning them to different diagnostic 
subgroups based on patterns of service use (Kessler, et al. 1999), by defining their main 
substance of misuse (Miles, et al. 2003), by defining their functional abilities (Luke, et al. 
1996), and by defining substance abuse as a primary disorder compared to those with 
psychoactive substance abuse disorder-induced organic mental disorders (PSUD-
induced-OMD) (Lehman, et al. 1994b).  
 The aforementioned studies illustrate the variance in determinants researched, but 
have failed to address how these determinants interact and which ones are the most 
meaningful for treatment planning. Another disadvantage of current research designs are 
the arbitrary groupings of determinants on some other basis, rather than on direct 
empirical findings, such as investigator judgment or prior established classification 
systems. By assigning individuals to arbitrarily designed subgroups, one must question 
the usefulness and meaningfulness of predetermined subgroups (Borgen, Barnett, 1987). 
New research in the field of co-occurring disorders should seek structure through 
subgroup (clustering) exploration versus confirmatory analysis. Once subgroups are 
empirically defined, researchers need to replicate the study in similar data sets to confirm 
the viability of the subgroups. When subgroups are empirically defined and replicated, 
researchers and clinicians can begin to explore antecedents and outcomes associated with 
homogenous subgroups with the intent to develop evidence-based programs. Cluster 
analysis is an effective methodology to examine the prevalence of different types of cases 
or subgroups present in a complex data set.  
 
Co-occurring Disorder Subgroups 
 The literature review, thus far, has discussed different strategies employed by 
managed care to assess and treat a population with varying degrees of illnesses (e.g. 
adjusted clinical groups, disease management, and consumer-treatment matching) and 
how the “burden of illness” is a better predictor of needed health resources than the 
presence of a specific disease or disorder. Although, there is no empirical evidence 
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supporting treatment matching for consumers with co-occurring disorders, there is reason 
to expect it will prove beneficial and equally useful as found in the MATCH Project 
(Luke, 1995). The remainder of the paper will explore conceptual frameworks attempting 
to define and classify co-occurring subgroups, as well as discuss applicable and available 
literature related to subgroups of individuals with co-occurring disorders. The following 
teams of researchers and future research identifying subgroups stands to promote 
additional understanding of the interaction of illness severity, psychosocial factors, and 
treatment outcomes for co-occurring disorders. 
 
Ries & Miller’s (1993) 
 The identification of subtypes is helpful for determining treatment matching 
paradigms to consumers’ level of care (Ries & Miller, 1993). In a conceptual paper, Ries 
and Miller (1993) proposed a four-cell model classifying consumers on the basis of an 
independent assessment of severity in each the mental health and substance abuse 
domains. The researchers developed the following diagnostic sub-groups: (a) Type I-
High-severity psychiatric/high-severity substance; (b) Type II-High severity 
psychiatric/low severity substance; (c) Type III-Low severity psychiatric/low severity 
substance; and (d) Type IV-Low severity psychiatric/high severity substance.  Ries and 
Miller have failed to provide empirically validated evidence to support their framework.  
Their results were later supported by the MATCH Project that discovered useful 
matching effects and encouraged researchers to focus on patient-treatment interactions 
effects as well as treatment or patient main effects. 
 
NASMHPD & NASADAD Model (1999) 
 In 1998, the National Association of State Mental Health Program Directors 
(NSAMHPD) and the National Association of State Alcohol and Drug Abuse Directors 
(NASADAD), under the support of SAMHSA, created a task force to explore service 
barriers to effective treatment for persons with co-occurring disorders. The task force 
adopted and expanded on New York State Office of Mental Health and the New York 
State Office of Substance Abuse Services conceptual framework for considering the 
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needs of the individuals with co-occurring disorders as well as system needs. New York 
adopted and modified Ries and Miller’s (1993) conceptual framework that considers the 
level of service coordination necessary based on the nature and severity of the 
individual’s disorders.  
 The underlying assumption of the revised NASMHPD & NASADAD model is 
that people with co-occurring disorders have varying degrees of service needs. 
Furthermore, the model moves consumers from consultation (Quadrant I), through 
collaboration (Quadrant II), to integrated care (Quadrant III), to those with the most 
severe need (Quadrant IV) (See Figure B.2). The model provides a mechanism in 
addressing symptom severity and level of care on a continuum from less severe to more 
severe disorders. The model is not intended to depict classification of consumers; rather, 
it displays the universe of individuals with co-occurring disorders (Minkoff, 2001; 
NASMPHD & NASADAD, 1999). As of today, the model has no empirical evidence to 
support its assumptions.  
 
Lehman’s Categorical Framework (1994) 
 Lehman et al, (1994) developed a categorical framework for delineating the 
heterogeneity among consumers with co-occurring disorders. The framework is a 
typology of subgroups defined by whether consumers are singly or dually diagnosed and 
whether their disorders are current or past. As seen in the other two conceptual models, 
Leman’s framework also presents consumers at varying degrees of comorbid psychiatric 
and substance abuse disorders.  As a result, there were ten possible subgroups and three 
mutually exclusive diagnosis subgroups (see Appendix D). 
 Based on a self report questionnaire, the consumer was assigned to one of the 10 
subgroups. Groups 7 through 10 were not considered in the final analysis or discussion 
due to the lack of representation.  In comparing the six subgroups, the only difference in 
their demographics (age, gender, race and martial status) was gender. The subgroups with 
current substance abuse disorders (group 1, 2, 3 & 6) had a higher percentage of men.  
Comparing psychiatric disorders among the groups found that approximately one-third of 
each group (1-6) had a diagnosis of schizophrenia or schizo-affective disorders, and 
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slightly over half had major affective disorders, about equally split between unipolar and 
bipolar disorders. Alcohol was the most commonly used drug reported for all groups. 
However there was a significant difference in usage patterns. Group 3 (substance induced 
organic; current) had similar usage patterns as those in group 6 (substance abuse disorder, 
only). The most interesting finding of the study was the further identification of three 
cluster groups in which all the subjects would fit (see Appendix E). 
 Lehman’s framework emphasizes the need to adopt a systematic approach for 
classifying subgroups within the context of co-occurring disorders. Like that of the 
MATCH Project, classifications contribute to the development of more effective 
treatments and services. This iterative process linking classification and treatment 
outcomes may in turn influence better systems of classification, thereby advancing 
treatment approaches. Classification systems encourage treatment planning and 
professional communication and discourage artificially constrained associations 
(Lehman, Myers, & Corty 2000). 
 
Luke’s Cluster Analysis (1996) 
 As stated earlier, co-occurring disorders is not a unitary construct but rather a 
disease concept that includes a wide variety of types of consumers with different histories 
of mental illness and substance use (Luke, 1996). Luke demonstrated the utility of 
analyzing the heterogeneity of a co-occurring inpatient population by examining the 
scores on an Addiction Severity Index (ASI). Seven scores (medical, employment, 
alcohol, drug, legal, family, and psychiatric functioning) on the ASI were used to group 
patients into seven homogeneous subgroups (best functioning, unhealthy alcohol use, 
functioning alcohol abuse, drug abuse, functioning polyabuse, criminal polyabuse, and 
unhealthy polyabuse). The study emphasized the various service needs of heterogeneous 
subgroups of consumers with co-occurring disorders. The best (highest) functioning 
subgroup would benefit most from a specialized short-term preventive treatment designed 
to link them up with existing community based supportive services to minimize 
recidivism whereas, individuals scoring functionally low on multiple domains would 
benefit most from a broad-based treatment condition (e.g. intensive case management, 
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extended individual and group therapy). Luke (1996) suggests that an important next step 
for co-occurring research is to replicate the formation of subgroups using different 
samples and settings (e. g. outpatient programs). 
 
Mueser’s Subgroups (2000)   
 A recent study conducted by Mueser et al, (2000) examined the relationship 
between patient characteristics and lifetime substance abuse disorders by focusing on 
prevalence, correlates, and subgroups of substance abuse disorders. The sample (N=325) 
consisted of a group of patients recently admitted to a psychiatric hospital and included 
patients living in rural, suburban, and urban areas of New Hampshire to improve 
generalizing to a broader population. Overall, the study found 58% of the study group 
met criteria for at least one type of lifetime substance abuse disorder (alcohol, cannabis, 
and cocaine). Alcohol was determined to be the most commonly abused substance, 
followed by cannabis.  
 Mueser and colleagues found univariate associations between patient 
characteristics and lifetime substance use. Their analyses indicated that younger 
participants were more likely to abuse cannabis and cocaine, rather than alcohol and 
those patients with cannabis use disorders had significantly lower levels of education. 
Patients with criminal histories were more likely to 1) have at least one symptom of 
conduct disorder, 2) one to three symptoms of antisocial personality disorder and 3) have 
all three types of substance abuse disorders.  
 Findings are consistent with previous studies of similar populations (Mueser et al. 
1990, 1992; Regier et al. 1990; Lehman et al. 1994) where alcohol is the most common 
type of substance abuse disorder, cannabis second and cocaine third.  Mueser and 
colleagues did find an interesting U-shaped, curvilinear relationship between age and 
alcohol use for patients who had been incarcerated and had an antisocial personality 
disorder. Younger patients ( 35 years) and older ( 48 years) patients were more likely 
to report an alcohol use disorder, whereas patients between 36 – 47 years did not. 
Research findings noted the relationship between cannabis and hospitalizations were in a 
counterintuitive direction: patients with one or more recent hospitalization were less 
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likely to have a lifetime cannabis use disorder, and the relationship could not be 
explained by age. In an earlier study conducted by Mueser (1990), patients with a lifetime 
history of cannabis misuse had significantly fewer lifetime psychiatric hospitalizations.  
 Several methodological strengths of the research included 1) the use of 
standardized, structured interviews and clinician reports, 2) prior consent by a large 
majority of patients eligible for the study, and 3) generalizability.  The overall goal of the 
study was to assess the performance of a nonlinear method by combining demographics 
with clinical characteristics to predict substance abuse disorders. Results indicate that 
demographic variables are strong indicators for specific lifetime substance abuse 
disorders among a psychiatric population. 
 
Statistical Critique 
 There has been extensive research examining the patterns and correlates of 
comorbid disorders (Kavanagh, Waghorn, Jenner, Chant, Carr, Evans, Herman, Jablensky 
& McGrath, 2002) but little has been done to explore how these patterns and correlates 
affect the probability of co-occurring subgroups. Furthermore, researcher’s often 
approach comorbid data with a single focus of observation or analytical technique that 
overlooks the significance of multivariate analysis. For example, Lehman’s (1994) 
categorical framework was a linear model developed on the basis of three questions and 
depending on the possible responses; ten subgroups were formed (see Appendix D).  
Participants (N=461) were selected from three psychiatric treatment facilities in an inner-
city catchment area and assigned to a group based on their answers to the three study 
questions.  Once in the groups, participants were evaluated through a structured 
diagnostic interview to compare clinical diagnosis and service needs.  Lehman’s study 
also investigated usage patterns within and across groups’ by examining the distribution 
of means and standard deviations taken from Addiction Severity Index (ASI) composite 
scores. As a result participants were later assigned to one of three clusters (see Appendix 
E). As mentioned earlier, these subgroups and clusters are arbitrary and reflect a 
researcher’s interest rather than an attempt to investigate the complex structure of 
comorbid disorders and/or the probability of authentic co-occurring subgroups. 
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Mueser et al., (2000) on the other hand examined the demographic and clinical 
correlates of substance abuse among recently hospitalized psychiatric patients. The focus 
of Mueser’s study was to explore the relationship between consumer characteristics and 
their life time substance abuse disorders. Inclusion criteria for study participants (N=325) 
included an Axis I psychiatric diagnosis and a contact with a clinician within the past 6 
months. Demographic information was taken from consumer charts and a structured 
clinical review was used to assess psychiatric and substance use diagnosis. A univariate 
analyses was conducted using a nonlinear method of data analysis (optimal data analysis) 
to determine if there was a relationship between characteristics and lifetime drug use 
disorders. A multivariate model, hierarchically optimal classification tree analysis or 
CTA (Yarnold et al., 1997), was used to predict alcohol use disorder from patient 
attributes.  Mueser’s study, unlike Lehman’s linear model that focused on distance 
between cases, focused on the number of subgroups supported by cases within the 
sample. Both researchers examined subgroup differences utilizing a small number of 
variables based on distances between respondents, rather than similarities in response 
patterns. Although their results suggest that empirically distinct subgroups exist within 
co-occurring disorder samples, they are limited in their utility.  
   Luke et al., (1996) utilized the statistical technique called cluster analysis on a 
large urban sample of psychiatric inpatient population (N=456). Cluster analysis is a 
statistical method that recognizes cases with distinctive characteristics in a heterogeneous 
sample and clusters them into homogenous groups (Luke et al., 1996). Luke’s research 
examined a large set of variables based on seven domains of the Addiction Severity Index 
(ASI) rating. Functioning levels in each domain (medical, employment, alcohol, drug, 
legal, family/social and psychiatric) were measured at the time of hospital admission. 
Using Ward’s (1963) clustering algorithm, the data suggested five to seven clusters. To 
validate the clusters, Luke et al. ran an additional clustering procedure known as (k-
means). The results supported seven clusters ranging in size from 34 to 100 group 
membership. The k-means clustering algorithm is used to partition data sets into pre-
determined number of groups or clusters that are homogeneous in terms of selected 
continuous variables (Magidson, 1988). The cluster algorithm chooses the number K of 
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clusters and selects variables to define those clusters and randomly positions each cluster 
at a point in the variable space. Each case is then assigned to the nearest k cluster using 
Euclidean distance. Finally the cluster means are computed and the clusters are 
repositioned at the centroid point. The problems in using the k-means approach are that a 
predetermined number of clusters must be identified beforehand and an arbitrary metric is 
needed for defining similarity or distance between clusters. Because there is no statistical 
criterion used to determine the number of clusters, the clusters depend on a random start 
that can bias results. 
 To better understand the utility of subgroups, Kessler (2004) suggests that 
multivariate profile analysis, such as latent class analysis, be performed to investigate 
unobservable structures that may exist among comorbid disorders. The differences from 
traditional clustering models, such as the one used in Luke’s et al., (1996) study, is that 
latent class analysis uses probabilities, instead of distances to define cases into 
subgroups/clusters. Furthermore, as researchers begin to explore complex multivariate 
data sets, they will need to employ statistical methods that are less restrictive and can 
handle nominal, ordinal and continuous variables, or any combination of the three, as 
latent class analysis allows. 
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CHAPTER III 
METHODOLOGY 
 
Participants and their Selection 
 Archival data of adults presenting for intensive outpatient treatment and/or case 
management for co-occurring disorders was re-analyzed for this study. The data set was 
selected due to its broad analysis of multiple domains taken from a large sample (N = 
816) of individuals diagnosed with co-occurring disorders presenting at an outpatient 
treatment program (Figure 3.1). According to Treatment Episode Data (TED, 2001), the 
average age presenting for treatment is 34 to 36 years with more males presenting for 
treatment with co-occurring disorders (56%) than females presenting for a similar 
treatment (44%).  TED 2001 reported racial/ethnic distribution among individuals with 
co-occurring disorders presenting for treatment, three-quarters were White (74%), 15 
percent were African American, and 7 percent were Hispanic. This archival data set 
contains 816 cases (N=816) of adult males (n = 424 or 52%) and females (n = 392 or 
48%). Over half of the participants were White (63%), and African American participants 
represented fewer than 35% of participants, while Hispanic or Latino only accounted for 
1% of participants. Their ages ranged between 25-34 (29.8%) and 35-44 (36.2%). 
 The participants for this study included a subset of the original sample, taken from 
the target population for the TCE SAMSHA Grant T1-12720. The original grant 
objective was to enhance and expand an existing outpatient program setting for treating 
co-occurring disorders, with the stated goal to “to develop the least restrictive and 
resource intense model of community-based dual-diagnosis treatment, while yielding 
results comparable to a residential program”. All participants were 18 years of age and 
older who were affected by co-occurring disorders of substance abuse and mental illness 
presenting for treatment in Davidson County, located in Nashville, Tennessee, between 
March 11, 2002 and September 30, 2004. All participants presenting for treatment during 
this time were assessed for eligibility by clinical intake staff. A group of assessment tools 
were used with established reliability and validity in populations that are predominantly 
diagnosed with substance dependency conditions and serious mood or thought disorders. 
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The original assessment process was used to determine participant’s appropriateness for 
an intensive outpatient program and/or case management. The complete protocol 
included both clinician-reports and self-reports to identify potential bias on the part of the 
clinician or the participant.  Clinical or research staff were available to individuals 
requiring assistance in completing self-reports upon request, i.e., reading, explanations 
and clarifications of terms and questions.   
 The original grant assessment protocol included prescreening, an intake 
assessment, a psychiatric evaluation and a psychologist or other specialized assessment as 
needed, such as vocational, nursing case management or laboratory test. A brief referral 
form was completed by the referring agency to obtain succinct diagnostic and treatment 
history during the prescreen process. As part of intake assessment protocol, a clinician 
conducted a comprehensive psychosocial interview in collaboration with administering 
several standardized assessment batteries (Addiction Severity Index (ASI), Brief 
Symptom Inventory (BSI), and Treatment Services Review (TSR), Co-occurring and 
Other Functional Disorders (COFD) Assessment Scale, Triage Assessment for Addictive 
Disorders (TAAD), Lehman’s Quality of Life (modified), SF-12 Health Survey. 
Psychiatrist interviews assesses 1) the need for pharmacotherapy; 2) diagnostic 
impressions using the multi-axial DSM-IV; 3) evaluation of co-morbidity conditions; 4) 
withdrawal risk;  and 5) treatment planning recommendations made by intake staff. 
Participants deemed appropriate for the intensive outpatient program (IOP) and/or case 
management were advised of the study and asked to participate. Participants expressing 
an interest in the original study were presented with a “Consent to Participate” form.  
Participants were excluded if the informant was deemed incapable of giving informed 
consent or would otherwise be unable to participate in the program. 
 For the purpose of this research the original non-probability, purposive sample 
(N= 816) was re-analyzed to distinguish participants who entered the outpatient program 
from those who received case management only. All participants entering the outpatient 
program, with or without case management, will constitute the sample used in the current 
research. Those cases receiving only case management, and not enrolled in the outpatient 
program, was excluded from the current research sample (Figure 3.1) 
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Figure 3.1. Data Subgroups: Original data sample consisted of participants enrolled in 
one of three programs. Data used for the current study included only two of the three 
programs (outpatient only and outpatient receiving case management). 
 
 
Instrumentation 
Government Performance and Results Act (1993) 
 SAMHSA used a battery of instruments to develop a measurement tool to assess 
the impact of drug treatment and prevention programs, in response to Public Law 103-62. 
The Government Performance and Results Act (GPRA, 1993; P.L. 103-62) requires 
federally funded programs to set performance objectives that result in measurable 
outcomes the government can use to improve policy decision-making, program 
effectiveness and public accountability. GPRA became the legislative framework for 
federally funded programs to set strategic goals, performance measurements, and report 
on the degree to which program goals are met. The intent of the GPRA is to lend 
structure to multi-program systems, like those found treating co-occurring disorders, by 
connecting substance abuse and mental health providers to a common policy/legislative 
directive (Kravchuk & Schack, 1996). With the implementation of the GPRA, the federal 
government has shifted its traditional compliance-oriented focus to a more results-
oriented decision-making design (Radin, 2000).  
Original Data Sample 
N = 816 
Outpatient 
Program Only 
(N = 395)  
Outpatient & Case 
Management 
(N = 285) 
Case 
Management  
(N = 136) 
Study Sample 
(N = 680)  
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  The premise behind the GPRA was taken from Osborne and Gaebler’s 
Reinventing Government (1992) that suggests strategic planning is necessary to improve 
social outcomes through long term visioning and setting outcome goals to achieve the 
vision (Kravchuk & Schack, 1996). With the implementation of the congressionally 
mandated GPRA, federal and local governments have created a systematic approach of 
collecting data for the purposes of measuring program outcomes, identifying national 
outcome measures, and improving access and quality to substance abuse and mental 
health treatment settings. Prior to the GPRA, federally funded program goals were poorly 
articulated and inadequate data on program outcomes were used to inform congressional 
policy makers on program funding decisions (Kautz, Netting, Huber, Borders, Davis, 
1997). Policy makers, with the use of performance measures, not only seek to improve 
existing programs, but rather to ensure a mix of programs within the system is having the 
intended effect.  Today, there is discussion among policy makers and practitioners 
debating if program success, determined through the use of performance measures, is a 
good indicator of consumer outcomes. However, determining the appropriateness and 
effectiveness of the GPRA is outside the scope of this paper. 
 Over the last 10 years, federal agencies have begun to explore the benefits of 
moving categorical programs, such as drug and mental health treatment programs, into 
performance partnerships requiring more accountability and collaboration from third-
party implementers. For the most part, these partnerships are made up of federal, state 
and local program managers who are collectively responsible for the design of the 
measurement instruments. Even though the point of focus for the federal government is 
performance and achieving system-wide objectives, state and local managers are 
provided flexibility to meet the diverse needs of their unique populations. Many 
providers’ gather additional data to assist them in addressing local and/or state specific 
service and treatment needs. 
  
CSAT GPRA Client Outcome Measures for Discretionary Programs 
 Performance measurements are consistent with SAMHSA’s co-occurring 
managed care initiatives and strategies mentioned earlier in the paper. In 1992, SAMHSA 
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created three centers, the Center for Substance Abuse Treatment, (CSAT), the Center for 
Substance Abuse Prevention (CSAP), and the Center for Mental Health Services (CMHS) 
to carry out SAMHSA’s mission of building resiliency and facilitating recovery (Mulvey 
& Atkinson, 2005). Prior to the implementation of the GPRA, SAMHSA was committed 
to improving the effectiveness, efficiency and accessibility to drug and mental health 
treatment by developing national outcome measures as part of a data collection and 
information management strategy generated within its own funded grant programs.   
 SAMHSA, (and therefore, CSAT) in 1998 created a grant program to achieve its 
shared goal of expanding substance abuse treatment services in communities nationwide 
to form the Targeted Capacity Expansion  (TCE) grant program. The instrument used to 
congressionally report TCE data, and used in the current study, was developed by 
SAMHSA, CSAT and TCE grantees through a participatory process. CSAT’s TCE 
program encouraged substance abuse and mental health treatment providers to become 
actively involved in the evaluation/performance process. Groups were formed based on 
target populations that included: adolescents, consumers with a criminal history, 
consumers on methadone maintenance, American Indians, women, co-occurring and 
other dysfunctional disorders, and consumers with or at high risk for HIV/AIDS (Atkins, 
Wilson, & Avula, 2005). 
 Groups formed under SAMHSA’s direction, identified demographic information 
and five co-occurring treatment domains to be measured and reported to congress. The 
development and approval (OMB No. 0903-028) of the “CSAT GPRA Client Outcome 
Measures for Discretionary Programs” is used to report treatment data nationwide on co-
occurring disorders at baseline, and again at 6 and 12 month follow-up interviews 
(Appendix F). Data collected at baseline on the CSAT GPRA is used to conduct the 
current retrospective analysis. All items used in CSAT’s GPRA outcome measures were 
taken largely from the Addiction Severity Index (ASI) and to a small degree the 
Treatment Services Review (TSR). The same seven domains found in the ASI and in the 
TSR were collapsed into five sections under CSAT’s GPRA (mental and physical health 
and alcohol and drug items were coupled under 2 categories instead of 4).  
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Addiction Severity Index (ASI-5) 
  The Addiction Severity Index (ASI) questionnaire was originally developed to 
measure treatment outcomes and assist researchers in evaluating treatment programs for 
substance abuse facilities (McLellan, Luborsky, Cacciola, Griffith, Evans, & Barr, 1985).  
The ASI measures frequency, extent and duration of substance use over an individual’s 
lifetime and during the 30 days prior to program intake (Grisom & Gragg, 1991; Corse et 
al, 1995; Butler et al, 2001) (Appendix G). 
 The originators of the ASI developed a semi-structured interview eliciting 
consumer’s self-reported problems in seven life domains: physical health, employment 
and financial support, illegal or criminal activity, family and social relationships, 
psychiatric symptoms, and drug and alcohol use and then measures those responses with 
the use of two indices –interviewer severity ratings (ISRs) and composite scores (CSs) 
(McLellan et al, 1985). At the end of each section the interviewer uses a 10-point scale 
(0-9) to rate problem severity, ranging from 0 (no treatment necessary) to 9 (treatment 
needed to intervene in life-threatening situation). The composite score is the result of two 
subjective questions asking the consumer to rate “How troubled or bothered they have 
been in a problem area over the last 30 days?” and “How important it is that they receive 
treatment for the problem?” in each of the seven domains. The score is based on a scale 
(0-4), with 0 meaning not at all and 4 meaning extremely.  
 McLellan et al. (1985) reported strong concurrent validity (.74 to .91) and test-
retest reliability (.92 or better) for 181 participants across three study groups from diverse 
treatment facilities. Participants were recruited from a Veterans Administration Clinic (n 
= 57), an inpatient substance abuse facility (n = 64), and a local psychiatric impatient 
facility (n = 60). Participants within the three different groups varied in age, ethnicity, 
gender and socio-economic status. Furthermore, between group differences were 
significant lending additional evidence to the concurrent validity of the ASI subscales. 
McLellan and colleagues demonstrated strong evidence for discriminant validity when 
they found correlations of r  .3 between social and psychiatric, legal and employment, 
social and alcohol, psychiatric and alcohol, and psychiatric and social dimensions. 
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 High inter-reliability was obtained in a 2-year longitudinal outcome study for 
consumers seeking treatment for substance abuse (Stoffelmayr, Mavis & Kasim, 1994). 
Stoffelmayr et al. (1994) was concerned if two assessors interviewing the same consumer 
would produce the same or similar scores and if each assessor would apply the same 
standards during different phases of a study. All assessors received the same criterion 
based training program and were judged to be trained once their scores for four 
consecutive assessments did not deviate more than 10% when compared to experienced 
assessments. Paired assessments (100) were conducted and videotaped throughout the 2-
year study. The ASI was administered to participants at admission to treatment, and again 
at 6, 12, and 18 month intervals. A primary assessor, conducting the actual field 
assessment, was paired with a second rater that observed the assessment. Both assessors 
recorded their scores independent of the other. In addition to the two independent 
assessors, an expert panel viewed the videotapes and produced a third score that became 
the standard. The researchers hypothesized that the mean differences would be less than 
0.1 for CSs and 1.0 for ISRs. Accuracy was calculated based on the difference between 
the two assessor scores and the standard. CSs showed inter-rater accuracy was high for 
both year one (m = 0 to .040) and year two (m = 0 to .045). ISRs were poor the first year 
(m = .952 to 1.286), but improved the second year (m = .429 to .952).  Intra-rater 
accuracy over time varied considerably on ISRs (m= .476 to 1.476), but achieved 
acceptable intra-rater accuracy on CSs (m=.014 to .046). Such findings point to CSs as 
being more reliable than ISRs and less prone to variations due to random error. The major 
finding of the longitudinal study established not only is inter-rater reliability high, but all 
correlations for reliability and accuracy were high (r = 0.90). 
 A test and retest reliability analysis on lifetime items of the ASI was conducted on 
108 male participants in an aftercare program at a veterans addiction recovery center 
(Cacciola, Alterman, Rutherford, McKay & Mulvaney, 1999). Eligible participants were 
required to have: completed a 4-week intensive outpatient rehabilitation program (IOP); 
used alcohol or cocaine within 6 months of IOP; a current mood disorder (DSM-3); an 
American Psychiatric Association (1987) lifetime diagnosis of cocaine or alcohol 
dependence; no history of psychotic disorders; a minimum degree of stability in living 
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conditions and a minimum literacy rate of the forth-grade. The ASI was administered 
twice to participants, once at intake for the IOP and again at baseline for the aftercare 
program. ASI assessors (n = 24) were trained extensively by A.T. McLellan, developer of 
the ASI. Data analysis evaluated continuous variables using intraclass correlation 
coefficients (ICC) and paired t tests to identify trends in the information. Reliability of 
categorical variables was evaluated using the kappa statistic. Findings support the overall 
reliability of the lifetime items in the ASI. All but two domains achieved acceptable 
levels of test-retest reliability; the family/social and psychiatric domains were reported to 
be poor to fair. The researchers suggest the longer interval test-retest reliability (1 to 3 
months apart) of the ASI lifetime items may have been biased by the consumer’s 
experiencing greater distress at the onset of the IOP program as opposed to the second 
administration prior to the aftercare program. 
 Other test and retest reliability studies, to the extent which information can be 
consistently obtained from respondents, have varied from acceptable to unsatisfactory. In 
a study of 98 homeless substance users, Zanis et al, (1994) calculated intra-class 
correlation coefficients for CSs (.76) and ISRs (.62) as compared to Spearman-Brown 
correlations for CSs (.86) and for ISRs (.75). When examining ASI CSs separately, five 
of the seven produced coefficients with acceptable values: medial (.93), alcohol (.87), 
drug (.70), legal (.81) and psychiatric (.89), while two domains received unacceptable 
values: employment (.50) and family/social functioning (.52). In a later study, conducted 
on 62 severely mentally ill substance abusers, Zanis et al. (1997) examined the internal 
consistency of items constructing each CS using Cronbach’s Alpha correlation coefficient 
(ranging 0 to 1). Researchers found only the legal composite score (.57) fell below 
acceptable internal consistency, while medical (.85), alcohol (.81), family (.73), and 
psychiatric (.77) CSs demonstrated good consistency, and employment (.68) and drug 
(.67) CSs were deemed satisfactory. When examining interobserver reliability, the 
investigators found coefficients associated with ISRs to be lower (Pearson .66 and 
Spearman-Brown .79) when compared to the CSs (Pearson .92 and Spearman-Brown 
.96).   
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 A recent study conducted on 400 male inmates, investigators compared the ASI to 
similar assessment tools and found the ASI to have predictive value, sensitivity, and 
overall accuracy when paired with the Alcohol Dependence Scale (ADS) (Peters, 
Greenbaum, Steinberg, Cater, Ortiz, Fry, & Valle, 2000). The study examined screening 
instruments to determine their accuracy in identifying alcohol or drug disorders, or both 
alcohol and drug disorder in prison inmates and found the ASI, when coupled with the 
ADS, to be highly effective in detecting substance dependency among prison inmates. 
The combination of ASI/ADS had desirable psychometric properties that were not 
affected by age, race/ethnicity, or education level.    
 In a commentary written by Cacciola and Alterman (2004), both researchers note 
a long list of studies supporting ASI’s construct validity in its ability to identify expected 
differences between men and women (Brown, Alterman, Rutherford, Cacciola, & 
Zagallero, 1994); homeless and housed individuals (Argeriou, McCarty, Mulvey, & 
Daley, 1994); antisocial and non-antisocial individuals (Cacciola, Rutherford, Alterman, 
& Snider,1994); consumers with and without co-occurring psychopathology (Cacciola, 
Alterman, Rutherford, McKay & Mulaney, 2001), drug and alcohol consumers 
(McLellan, Kushner, Metzger, Peters, Smith, Grissom, Pettinati, & Argeriou, 1992B). 
Reliability, validity and construct studies have repeatedly supported the use of the ASI 
among comorbid substance abusers seeking treatment. However, studies have shown that 
ISRs and CSs do not achieve consistent reliability and considerable limitations exist 
when administered to populations outside its intended use.  
 In the matter of co-occurring disorders, the ASI has been found to be less reliable 
and valid as the level of psychiatric severity increases (RachBeisel et al., 1999; Hodgins 
et al., 1992; Zanis, McLellan, & Corse, 1997). Corse and colleagues (1995) found that the 
ASI had limited utility when administered to consumers with both severe and persistent 
mental illness and substance abuse problems. Most researchers concur that the ASI 
retains good utility as a reliable instrument for use with individuals with less severe 
psychiatric disorders (Lehman et al. 1985; Stoffelmayr et al. 1994; Cacciola et al. 1999; 
Cacciola & Alterman, 2004; RachBeisel et al. 1999; Hodgins et al., 1992; Zanis, 
McLellan, & Corse, 1997). For consumers suffering from severe and persistent mental 
  46 
illness research suggests the use of additional instruments for a more comprehensive 
assessment of psychiatric symptomology and functioning. Since the purpose of the 
present study is to identify homogeneous groups within a large outpatient treatment 
program by examining five areas of functioning, and not to assess or determine problem 
severity, the use of the ASI is appropriate for the current investigation of: (1) subgroups, 
(2) group differences, and (3) utility of subgroups for treatment planning.  
 In summary, the ASI continues to be used with persons with severe mental illness 
and substance abuse disorders, despite the inconsistent empirical evidence supporting its 
validity, reliability and general usefulness in measuring co-occurring disorders.  This is in 
large part because there have been no instruments developed to assess addiction severity 
among persons with severe mental illness and substance abuse disorders until recently. 
The Dartmouth Assessment of Lifestyle Instrument (DALI), a brief screening instrument 
was developed to detecting recent (within 6 month) substance abuse disorders in persons 
with severe mental illness. The Dartmouth Assessment of Lifestyle Instrument (DALI) 
identifies three types of substance abuse disorders: alcohol, cannabis and cocaine 
(Rosenberg, Drake, Wolford, Mueser, Oxman, Vidaver, Carrieri, & Luckoor, 1998). 
Empirical evidence on the DALI has yet to surface, but initial findings indicate high 
concurrent validity for both alcohol (.74) and drug (.83) use disorders (Rosenberg et al. 
1998; Peter, 2003). A copy of the ASI can be found in the Appendixes (Appendix F). 
 
Treatment Service Review (TSR-5) 
 The TSR (McLellan, et al. 1992A) closely resembles the outcome categories of 
the ASI and is often administered together. The TSR is a 5-10 minute structured 
interview that measures type and frequency of alcohol and drug treatment services an 
individual receives weekly in seven areas of functioning encompassed by the ASI. The 
initial findings indicate the TSR has good test-retest reliability, concurrent validity in 
differentiating between levels of care, and offers a means of evaluating the “match” 
between a consumer’s service needs to the actual services they receive (McLellan, et al 
1992A). Each problem area is divided into four sections. The first section asks the 
consumer to report the number of days they were effected by a target behavior during the 
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past week or month. Examples of the types of questions asked include the number of days 
the consumer experienced significant medical problems, committed a crime, worked, 
drank alcohol, or had a significant conflict with a friend or family member. The second 
section requests the number of times during the past week/month they received services 
from a professional. The third section inquires about the relevance of the services 
received. The fourth section asks the consumer if the services received were provided 
from an inpatient program or by separate outpatient programs. The TSR is an extension 
of admission information asked in the ASI and is designed to measure substance abuse 
treatment; whereas, the ASI measures the substance abuser.  
 Alterman and McLellan (1993) used the TSR to compare the quantity and patterns 
of treatment cocaine dependent patients received in two Department of Veterans Affairs 
intervention programs. The investigators were interested in determining the similarities 
and/or differences between the inpatient and day hospital program. Alterman and 
McLellan hypothesized that the inpatient program would provide more services, 
specifically in the areas of drug, alcohol, psychiatric and medical areas. A multivariate 
analysis of variance (MANOVA) was performed comparing the day hospital program to 
the inpatient program. A statistical significant outcome was obtained (F(88) = 7.23, p  
.01) indicating program differences in the amount and patterns of services provided. 
Contrary to the investigators hypothesis, patients participating in the day hospital 
program received significantly more employment services (p  0.001), medical services 
(p  0.095), alcohol services (F (94) = 4.90, p  0.008) and more drug related services 
(F(94) = 7.36, p  0.008) than those participating in the inpatient program. Overall, the 
findings provide evidence that the TSR can characterize the differences between 
treatment programs and has predictive utility above that offered by patient characteristics. 
A copy of the TSR can be found in the Appendixes (Appendix G). 
  
Data Collection 
 Original data used in the current study was collected by Foundations Associates 
(FA) located in Davidson County, Tennessee. Foundation Associates obtained a model 
status for integrated treatment for co-occurring disorders from SAMSHA (2000) as one 
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of the three exemplary programs in the United States. FA’s was featured at the Co-
occurring Institute of the SSDP V (State System Development Program 5th) Conference, 
and the residential services were selected as a finalist for the American Psychiatric 
Associations’ (APA) Gold Achievement Award (2000). FA’s programs are based upon 
key elements best described by Minkoff, 2000) as the seven principles inherent in an 
integrated model of care for co-occurring disorders. The actual collection of the data was 
preformed by master level, research assistants under the supervision and training of the 
Principle Investigator. The data used in the current study was collected using the CSAT 
GPRA through self-report. The self-reported data was then entered, by original data 
collector, into a secure governmental data bank within 10 days of collection. 
 The five domains making up the CSAT GPRA collection instrument can best be 
defined as a consumer profile that measures social functioning and adjustment, if a 
consumer is receiving social/medical services aimed at restoring social functioning, as 
well as evaluating current and lifetime substance use. Consumer profiles made up of an 
individual’s responses were captured in CSAT’s GPRA outcome instrument measuring 
five areas of functioning. Drug and alcohol items focuses on obtaining information about 
the frequency of a consumer’s substance use during the last 30 days prior to treatment 
entry and the number of years a consumer has abused substances (lifetime use). The 
items found in family and living condition section is a combination of both the ASI and 
the TSR. The focus of the section is to obtain information on where the individual has 
been living and if their substance use has added stress or emotional problems to their 
living conditions. Education, employment and income are straight forward questions 
taken from the ASI. The legal section asks three questions taken from both the ASI and 
the TSR. The mental and physical health problem and treatment items are taken from the 
ASI and the TSR. Questions inquire about the consumer’s overall health at the time of the 
interview, what types of treatment they have received in the last 30 days and how many 
days in the last 30 days have they experienced emotional problems. Key domains and 
study variables, shown in Table 3.1, are found on the CSAT GPRA (Appendix F) which 
is comprised of questions taken from the ASI and the TSR. 
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 To obtain the archival data necessary for the study, and under the supervision of 
committee members, a Data Release Agreement (see Appendix I) was forwarded to the 
original grantee (Foundation Associates’, Nashville, TN) of the TCE SAMSHA Grant 
T1-1272. The agreement outlined terms and conditions for the explicit use of the data 
with restrictions. Approval of such conditions was made between the current investigator 
and the operating data owner (Michael Cartwright, Founder & President of Foundation 
Associates’). To protect consumer confidentiality, an agreement disclaimer  required all 
personal identifiers (name, address, social security number) and other direct personal 
identifiers be purged prior to data transfer and require an encrypted electronic link file be 
maintained by the operating data owner. The data was made available upon the approval 
of the Data Release Agreement. The data was transferred on an SPSS file ready format, 
via a compact disc secured with an encrypted password for entry. The data set included 
all baseline information recorded on CSAT GPRA Client and approved by the University 
of Tennessee’s IRB to use in current study. 
 
 
Table 3.1  Key Domains/Study Variables 
Key Domains                  Variables                  Measurements 
Substance Use  Substance Use (days used/type of substance)       Count, Multi-categorical 
   (Alcohol, Alcohol use to intoxication -# of drinks) 
Family/Living  Housing (Shelter, Street, Institution, Housing)  Multi-categorical 
   Stress related to substance use.   Ordinal – Categorical  
   Reduction of activities due to use.   Ordinal – Categorical 
   Emotional problems due to use.   Ordinal – Categorical 
Education/Employment Enrollment in school/job training.   Multi-Categorical 
   Education Level/Employment   Count, Multi-Categorical 
   Income (variety of sources)    Ratio 
Criminal History  #Arrest, Drug Related Offenses, # days in jail        Count 
Health   Overall Health     Ordinal - Categorical 
   Treatment Services (inpt, oupt, emergency, # of Days) Count - Categorical 
   Emotional Problems (# of days experienced serious Count - Categorical 
   depression, anxiety/tension, hallucinations, trouble  Count (# of days) 
   concentrating, controlling violent behavior, suicide Count (# of days) 
   attempts, problems with prescribed medication)  Count (# of days) 
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Research Design 
 The exploratory research was conducted through a retrospective analysis to seek a 
parsimonious model of subgroups made up of individuals with co-occurring disorders 
entering an outpatient program. The current research proposes to identify homogeneous 
subgroups by analyzing case level data (substance use, medical, behavioral, and 
psychosocial factors) using a latent probabilistic clustering approach. Instead of using 
Euclidean distance to assign cases to the nearest group, cases were classified into groups 
using model based posterior membership probabilities. Advantages of using a 
probabilistic clustering approach involves:  1) minimizing the with-in group variation and 
maximizes between group variations; 2) less researcher bias in group assignment; 3) 
allowing observed variables, with groups, to have varied distributional forms, normal 
distributions with unknown variances and mixture models ( Vermunt & Magidson, 2003).  
 Data taken from CSAT’s GPRA instrument on the five domains, as presented in 
Table 3.1, were evaluated to answer the following research questions: 
1. Do homogenous subgroups exist in the sample of adult individuals entering an 
 outpatient program for co-occurring disorders? 
2. How many homogeneous subgroups exist? 
3. How well does the model fit the data? 
4. What are the size and nature of the homogeneous subgroups? 
5. What are the psychosocial variables associated with subgroup membership? 
6. If no subgroups exist, what other research attempts should be made to explore  
 the heterogeneity of co-occurring disorders. 
The answer to the main research question: Do homogeneous subgroups exist in the 
sample of adult individuals entering an outpatient program for co-occurring disorders?” 
was determined by examining the pattern responses of the observed variables. A 
probability modeling approach, Latent Class Analysis, was used to explore if there are 
meaningful response patterns among the five categorical domains mentioned in Table 
3.1. 
 A latent structure model is supported by distinctive subgroups taken from the 
sample, descriptive statistics were computed and reported by group to answer the 
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research questions: “What are the size and nature of the homogeneous subgroups?” and 
“What are the psychosocial variables associated with subgroup membership?”  
Correlates between indicators were examined to define and explain group membership, 
with specific attention to substance use. Consistent across all studies, researchers 
associate heavy, long-term alcohol disorders with more severe mental disorders where 
state hospitals, jails and emergency rooms are the locus of care (Quadrant IV, 
NASMHPD & NASADAD Model, 1999). Literature also provides evidence of a 
framework that indicates subgroups of individuals with co-occurring disorders can be 
determined by their level of functioning and patterns of substance abuse. Individuals, 
based on their responses, are assigned to interventions that emphasize intense inpatient or 
community based programs.  These findings and theories were tested in the current study 
by evaluating the relationships between social functioning (criminal history, housing, 
employment/income, and level of education), illicit substance use (alcohol, marijuana, 
and cocaine), and physical and emotional problems (depression, anxiety, hallucinations, 
suicide attempts, violent behavior, trouble concentrating and side effects of medication). 
  
Data Analysis 
 The first four research questions of this study were designed based on the 
assumption that individuals belong to discrete groups with respect to an unobserved 
categorical latent variable where values consist of qualitatively different subgroups. The 
indicators used to detect the latent variable may consist of mixed measurements. 
Research questions pertaining to subgroup identification are as follows:  
 1.  Do homogenous subgroups exist in the sample of adult individuals entering an 
  outpatient program for co-occurring disorders? 
 2. How many homogeneous subgroups exist? 
 3. How well does the model fit the data? 
 4. What are the size and nature of the homogeneous subgroups? 
   
Based on this assumption, latent class analysis (LCA) was used to determine the 
existence and number of subgroups founded on similarity in response patterns rather than 
distance between respondents.  LCA is a statistical technique that identifies the smallest 
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number of mutually exclusive groups of individuals with similar patterns of responses 
and helps explain relationships among observed variables. 
 LCA is a multivariate statistical procedure that calculates the probability that an 
individual will belong to a specific group while each group represents a distinct profile of  
observed symptom endorsement probabilities (SEPs; i.e. the likelihood of having a 
symptom given membership in a group) that is consistent among all members in the 
group (Chung & Martin, 2005). The analyses was done using Latent GOLD 4.0 (Vermunt 
and Magidson, 2000). Latent Gold 4.0 was chosen for its flexibility to analyze a complex 
data set of mixed scale type variables (nominal, ordinal, continuous and counts), and 
where missing data can be imputed as a part of the process. The manifest/observed 
variables represented in the five mutually independent constructs of CSAT’s GPRA 
(substance use, family/living, education/employment, criminal history, physical and 
emotional health) were analyzed in two stages. The observed or study variables are 
referred to as indicator variables in Latent GOLD 4.0. 
 First, an exploratory LCA was conducted to obtain optimal group-solutions by 
stepwise addition, until the model fits the data or no longer improves. A model estimation 
of 1- 4 groups were computed as a starting point. Based on summary results, additional 
groups were added or deleted until the best solution is reached.  Latent Gold software has 
built into its program the Expectation Maximization (EM) algorithm to estimate model 
parameters and an iterative process that updates the original model expectations with the 
estimates until the log-likelihood (LL) function becomes smaller and the p-value 
indicates the model is consistent with the data.  This process ensures that the estimates of 
the parameter values have converged at a maximum likelihood. To determine the most 
parsimonious model and best fit to the data, a p-value greater than (.05) for a likelihood 
ratio chi-square (LRX) statistic, followed by the fewest number of parameters (Npar), and 
an information criteria indices were selected i.e., Akaike (AIC) and Bayesian (BIC).  
Latent GOLD offers an alternative option to assess model fit, by using the bootstrap of 
LRX to re-estimate the p-value. This is an important function because the LRX assumes 
that the statistic follows a chi-square distribution and by relaxing that assumption, 
estimating the statistic becomes more accurate. Instead of assuming the shape of a 
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group’s distribution, the bootstrap method was used to determine the probability of the 
group’s distribution from the data itself.   
 The fifth research question, “What are the psychosocial variables associated with 
subgroup membership?” was answered using parameter and profile output generated 
from Latent GOLD.  The Wald Test p-value and Z statistics were used to determine if 
each indicator (observed variables) contributes in a significant way towards the ability to 
discriminate between the groups. Next, R² would be computed to predict class 
membership by measuring group variance for each indicator. Higher values of R²  
(measures between 0 and 1), would mean an indicator has greater ability to predict group 
membership than another. To further understand group characteristics, Latent GOLD   
provided output on conditional probabilities that show the differences in response 
patterns among the groups. In order to distinguish the groups, descriptive names were 
assigned to each group, based on information from the R-squared statistic and the 
conditional probabilities of each group. Once the groups were named, a profile plot 
(column percentages) is used for graphical representation showing the probabilities, 
given in a group, of having that answer pattern for the set of indicator variables.  A modal 
assignment method, a cross-tabulation of frequencies, was analyzed to further define 
observed patterns of responses and the probability of someone being in a specific group.  
Finally, a diagnostic statistic, the bivariate residual, was computed to identify any 
weaknesses in explaining associations between indicators. “The bivariate residual (BVR) 
corresponds to a Pearson chi-square statistic (divided by the degrees of freedom) in 
which the observed frequencies in a two-way cross-tabulation of the indicators are 
contrasted with those expected counts estimated under the model” (Vermunt & 
Magidson, 2003). A BVR value substantially larger than 1suggests the model falls short 
of explaining the association between two indicators and BVR values larger than 2.4 are 
unacceptably high (Vermunt, 2000) . In the event that a BVR value is greater than 1, 
additional groups may be added. 
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CHAPTER IV 
RESULTS 
 
Demographic Characteristics 
 Study participants totaled (n = 680) where 54% (369) were female and 45% (311) 
were male. Program participants were typically 25-45 (68.4%) years of age (M = 36.23, 
SD = 9.55). Females (51%) presented for treatment at a younger age (18-35 yr) than men 
(40%) in the same age bracket. The oldest study participant was a 70 year old female 
(Table 4.1).   
 
Descriptive Statistics 
 
 The following section discusses descriptive statistics on the indicators explored 
under the current research. First, missing data were examined using SPSS missing value 
analysis (MVA) and based on rates of missing information for a latent class analysis, 
where rates of over 30% for a two-class model are not considered reliable and rates over 
40% for a three-class model become less reliable in predicting true class membership  
 
 
Table 4.1  Demographic Characteristics  
Indicator      n     %        
Male     311 45.7% 
Female     369 54.3% 
Ethnicity White   421 61.9% 
  African American 253 37.2% 
  Other      4            .4% 
  Missing      2    .2% 
Age Group 18-24    94 13.8% 
  25-35   221 32.5% 
  36-45   244 35.9% 
  46-55   109 16.0% 
  Over 55    12  1.8% 
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(Harel & Miglioretti, 2005; Bandeen-Roche, Miglioretti, Zeger, & Rathouz, 1997). Latent 
class analysis takes into account missing data so that all the data is considered for  
analysis.  When using LCA it is not necessary to delete cases that have partial data 
because the software computes the missing data by utilizing a full-information 
expectation-maximum likelihood estimate (EM-MLE) of parameters. An expectation-
maximum likelihood (EM-MLE) is used in statistics for finding maximum likelihood 
estimates of parameters in probabilistic modeling approaches (Vermunt & Magidson, 
2000). EM-ML assumes the data are missing at random, however if this assumption is not 
meet, the EM-ML technique performs better than list or case deletion (Vermunt & 
Magidson, 2000). Further review of indicators, using SPSS case summary reports and 
Little’s MCAR test, found response patterns for certain types of substances, treatment 
services and the mental health indicators to be uniformed non-responses or missing 
completely at random (MCAR) (χ2 = 46.27, df = 62/ p = .93). All missing data are coded 
and an iteration process set at 100 (maximum number of iterations for all estimates to 
converge) is implemented by the EM algorithm. Given the large missing value rate 
among many of the mental health indicators, hallucinations (68.7%), trouble 
understanding and concentrating (68.8%), trouble controlling violent behavior (68.8%), 
attempted suicides (69%) and problems associated with prescription medicine (68.7) 
were excluded as single indicators and combined later into one indicator for model 
estimations and significance testing.  In Table 4.2 variables for which there was a 
substantial amount of missing data and later deemed insignificant in determining a model 
are displayed. 
 In Table 4.3, alcohol, marijuana, cocaine and opiate use was measured as a count 
variable (days used within the last 30 days) indicating 48 % of the sample (N = 680) 
reported using alcohol (M 6.49 = SD = 8.41), 28% of the sample reported using 
marijuana (M 4.05 = SD 7.22) and 44% reported using cocaine (M =5.06, SD = 7.96). As 
shown in Table 4.4, participants were asked about their housing in the last 30 days and a 
majority of study participants (621) reported having housing most of the prior month. 
Housing was defined as owning or renting an apartment, room or house; living with 
someone, living in a halfway house or enrolled in a residential program. When asked how  
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Table 4.2  Missing Value Analysis  
       Indicator                 Missing (count)             % 
 Substance Use  
  Heroin, Morphine, Diludid, Demerol, Percocet,      290  42.6 
  Darvon, Codeine and Opiates (Days used)   
Service Treatment 
  Inpatient Treatment (how many days) for: 
   Physical complaint     302    44.4  
   Mental or emotional difficulties    258    37.9 
   Alcohol or substance abuse    267    39.3 
  Outpatient Treatment (how many days) for:    
   Physical complaint      308   45.3 
   Mental or emotional difficulties   261  38.4 
   Alcohol or substance abuse    284  41.8 
  Emergency Room Treatment (how many days) for: 
   Physical complaint     269  39.6 
   Mental or emotional difficulties   274  40.3 
   Alcohol or substance abuse    289  42.5 
Mental Health  
  Experienced hallucinations (how many days)   467  68.7 
  Trouble understanding/concentrating    468  68.8 
  Trouble controlling violent behavior    468  68.8 
   Suicide attempts       469  69.0 
  Experience problems with medication    467  68.7 
  
 
 
Table 4.3  Substance Use in Past 30 Days   
Variable    Response              n  %    Mean (SD) days    
Alcohol Use   No Use  356 53%   6.49 (8.41) 
   Use  324 48%       
Marijuana Use  No Use  500 74%   4.05 (7.22) 
   Use  180 26% 
Cocaine Use  No Use  383 56%   5.60 (7.96) 
   Use  297 44% 
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Table 4.4  Housing and Substance Use Problems 
 
Variable                             n         
Housing    
 Shelter       25      
 Street     13     
 Institution      2    
 Housed    621      
 Missing      19     
Stressed due to substance use 
 Not at all   125    
 Somewhat    91   
 Considerably   157     
 Extremely   279   
 Not Applicable    26   
 Missing       2    
Reduction in activities due to use 
 Not at all   186   
 Somewhat    77      
 Considerably   124   
 Extremely   264   
 Not Applicable    26   
 Missing       3      
Emotional problems due to use 
 Not at all   167   
 Somewhat    89      
 Considerably   123   
 Extremely   272     
 Not Applicable    26   
 Missing       3    
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their substance use affected their stress level, caused them to give up important activities 
or caused emotional problems, most answered being extremely effected by all three 
indicators. 
 A majority of participants (98%) were not enrolled in school or a vocational 
training program within the last 30 days (Table 4.5). Only 21% of participants reported 
working full-time in the last 30 days, while 49% reported being unemployed, but looking 
for work. When considering income, as seen in Table 4.6, only 153 (22%) of the 680 
participants reported receiving wages during the last 30 days  with an average monthly 
income of less than $226 (M = $225.74, SD = $612.23), with only 10% receiving, on an 
average less than $25 a month for public assistance (M = $24.81, SD = $92.94). Most 
participants also reported receiving little to no retirement income (M   = $4.47, SD = 
$81.52). The average disability income reported was less than $130 (M = $129.59, SD = 
$360.75). Criminal history, as displayed in Table 4.7,  indicates that most participants 
(92%) were not arrested during the last 30 days (M = .09, SD .32), with 53 individuals (or 
8%) of the sample reporting 1 to 3 arrests during the same time frame, with 23 of them 
being arrested for a drug offense. Those being arrested spent an average of 1.5 days in jail 
(M = 1.57, SD = 7.48). 
 The domain measuring a participant’s health included overall and mental health 
shown in Table 4.8 suggests a majority of the sample reported having very good to good 
overall health (M = 3.31, SD = .099) at baseline. For those individuals reporting days they 
experienced mental health problems within the past 30 days, depression (M = 15.37, SD = 
12.79) and anxiety (M = 15.05, SD = 12.95) were similar (Table 4.9). All other mental 
health indicators reported low frequency counts. This can in part be due to the high 
prevalence of comorbidity between substance abuse and mental illness which requires a 
presumptive, and not necessarily a definitive diagnosis. 
 
Latent Class Analysis 
 The following section presents the results of the analyses used to answer the main 
research questions: If homogeneous subgroups exit in the sample and if so, do the 
subgroups represent a parsimonious model? Results of the likelihood ratio Chi-squared, 
  59 
Table 4.5  Education/Employment   
 
Variable                     n    %      
Enrolled in School or Job Training 
 Not Enrolled    667  98%    
 Enrolled, Full Time      5  .7% 
 Enrolled, Part Time      4  .6% 
 Other        2  .3% 
 Missing        2  .3% 
Educational Level 
 Less than High School   103  15%   
 Obtained some High School   396  58%   
 Some College    177  26% 
 Some Graduate School        4   .4% 
Employment Status 
 Employed Full-Time   139  21%   
 Employed Part-Time    42    6% 
 Unemployed Looking for work  335  49% 
 Unemployed Disabled    73  11% 
 Unemployed Retired     5    1%  
 Unemployed not looking for work   43    6% 
 Missing Data     43    6% 
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Table 4.6  Mean Income  
 
Variable                    n  %   Mean (SD) in dollars   
Income (Dollars) 
 Income from Wages   
  Reported No Income 525 77% $225.74 ($612.23) 
  Reported Income  153 22% 
  Missing      2 .2% 
 Public Assistance    
  No Public Assistance 604 89%  $24.81   ($92.84) 
  Received Assistance  74  10% 
  Missing      2 .2% 
 Retirement 
  No Retirement  675 99%  $ 4.47 ($81.52) 
  Received Retirement    3 .4% 
  Missing      2 .3% 
 Disability 
  No Disability  545 80% $129.59 $(360.75) 
  Received Disability 133 19%  
  Missing      2 .2% 
 
 
Table 4.7  Criminal History   
 
 Arrest/Jail                  n    %     
Arrest in the past 30 days: 
 No Arrest   627  92%   
 1-3 Arrest     53   8%  
Drug related arrest past 30 days 
 No Arrest   655  96%   
 1-3 Arrest     23    3% 
  Missing        2   .3% 
Nights in spent in jail 
 No nights in jail   620  91%    
 Spent nights in jail   58    8% 
 Missing        2  .2%  
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Table 4.8  Overall  Health    
Variable                 n  %    Mean (SD)    
Overall Health 
 Excellent   23  3%  3.31 (.99) 
 Very Good  110 16% 
 Good   260 38% 
 Fair   205 30% 
 Poor     82 12% 
 
 
 
Table 4.9   Mental Health Problems    
Days Troubled by:                    Mean   (SD)   
Serious Depression     15.37  (12.79) 
Serious Anxiety/Tension     15.05  (12.95) 
Hallucinations        2.28  (13.05) 
Understanding/Concentrating      2.20   (6.76) 
Suicide Attempt          .11        (.43)  
Prescription Medication         .74   (3.59)  
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information indices, Akaike and Bayesian Information Criterion (AIC and BIC), 
Bootstrap statistics, BVRs and a meaningful explanation of group membership are 
presented in determining subgroups and a model. The second set of research questions 
pertaining to the nature of each subgroup and the psychosocial variables associated with 
subgroup membership is determined by the Wald Test, analysis of the conditional 
probabilities and bivariate residuals. 
 
Preparing Variables for the Analysis    
 To estimate a model, five domains with multiple indicators (substance use, living 
conditions education/employment, criminal history and health) were taken from the 
GPRA and analyzed through the use of Latent Gold 4.0 (Vermunt & Magidson, 2000), a 
latent class analysis software. The software was chosen in part for its ability to estimate 
latent models with missing data by providing maximum likelihood (ML) estimations 
under missing completely at random (MCAR) for mixed variables. As indicated earlier 
(Table 4.2) many indicators had a high percentage of missing data and were eventually 
excluded as single indictors from analysis due to their insignificance in determining a 
model. The pattern of the non-response (MCAR) items in Table 4.2 can be partly 
addressed under several assumptions.  The separate illegal drug indictor was answered 
while reporting which illegal drugs were used was not answered. Missing service 
treatment information is likely to represent a response of “no” or “not applicable” 
treatment received in the last 30 days. When considering the large amount of missing 
information on the mental health indicators, three important thoughts will be discussed in 
greater detail later in the paper: 1) consumers presenting for outpatient treatment services 
are less likely to exhibit severe mental health problems such as hallucinations or suicide 
attempts,  2) a co-occurring disorder, due to the high prevalence of comorbidity between 
substance abuse and mental illness, often requires a presumptive, and not necessarily a 
definitive diagnosis is given early in treatment and 3) what are the consequences of the 
missing information on data analysis and subsequent interpretation of findings.  Needless 
to day, latent class analysis frames the missing data as a response pattern and connects 
both the observed and missing patterns in the likelihood function in models with 
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incomplete data (Grinkel, Vermunt, Andries van der Ark, & Sijtsma, 2007; Vermunt & 
Magidson, 2000).  
  To answer the research questions, Latent Gold 4.0  authors’ of the software 
suggest that model estimations begin with a range from 1-4 clusters using the criterion of 
maximum-likelihood estimates (MLE) through numerical optimization, utilizing an 
iterative method to estimate model parameters. As classes are added 2, 3...n, model fit 
tends to improve. Latent subgroups are structured on observed variables that are 
uncorrelated within any one group. An essential assumption of LCA is that of 
“conditional independence” where the observed study indicators (made up of several 
response items) are statistically independent within each subgroup. 
 During the first attempts in estimating the model, an analysis of the bivariate 
residuals found many indicators appeared to violate the assumption of conditional 
independence. Response patterns indicated a lack of “conditional independence” among 
indicators. Conditional independence requires all indicators be statistically independent 
(uncorrelated) within each latent subgroup. Early model estimations indicated count 
variables such as substance use (alcohol, alcohol use to intoxication, illegal drug use, 
opiate, marijuana and cocaine), and mental health (depression, anxiety, tension, trouble 
controlling violent behavior and hallucinations), as well as mixed variables representing 
criminal history (number of arrest, number of drug arrest, and nights spent in jail), and 
housing (shelter, street, institution, own/rent, living with someone, residential, halfway) 
exceeded number of allowed response categories or had dependent response items. 
 First, because LCA has constraints on number of response items per indicator, 
count (number of days having over 30 different responses) and multi-categorical 
variables were recoded using SPSS to collapse responses into fewer items. Count 
variables were recoded into ordinal-categorical response items (no use,  15 days use, 
and 16 days use) and multi-categorical variables were recoded into binary responses 
(arrest/no arrest and housed/not housed). These constraints reduce the number of 
parameters that require estimation and promote parsimony. Next, to eliminate dependent 
items that would promote the emergence of extra, spurious latent classes, two or more 
variables were combined to form one new variable. Using SPSS new variables were 
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based on combining responses for substance and mental health indicators.  Illegal drugs, 
cocaine and marijuana were combined to form an illegal drug variable and  serious 
depression, anxiety, hallucinations, lack of concentration, violent behavior, suicide 
attempts, and medication problems were combined to form a mental health variable.  
 
Estimating the Model 
  To determine the number of subgroups within the sample, an estimation of 1- 4 
subgroups was used. Using all indicators, early model estimations were inconsistent with 
the data (p-value .05) suggesting that one or more of the indicators were insignificant in 
determining a model. In latent class analysis, the null hypothesis is that “there is no 
difference between what the model is predicting and what the data are doing”.    In 
determining a parsimonious model the researcher wants the model to be consistent with 
the data. To identify which indicators were significant in determining a model, several 
model estimations were conducted by removing, and re-adding one indicator at a time. A 
model consistent with the data comprised of four ordinal-categorical indicators (alcohol 
use, illegal drug use, education and serious depression). The illegal drug indicator 
represents responses items taken from illegal drugs, cocaine and marijuana. The serious 
depression indicator represents a single variable and not the combined variable termed 
mental health. The Wald Test p-value ( .05) was used to determine statistical 
significance among the four indicators.  Living conditions, employment/income, criminal 
history and many of the mental/physical health variables were not significant when 
determining subgroups within the model. Model fit was assessed by the chi-squared 
likelihood ratio (L²) p-value .05, and based on the assumption that the L² statistic 
follows a chi-squared distribution. The L² statistic should not be substantially larger than 
the degrees of freedom. The L² statistic is useful in determining the amount of association 
among variables that remains unexplained in the model; the lower the value, the better 
the fit of the model to the data. Along with analyzing the L² statistic, two parsimony 
indices were used were smaller values correspond to more parsimonious models. Using 
these criteria, and considering the least number of parameters, Model-2 (L² = 113.78, p = 
.05, BIC = 5053.14, AIC = 4980.78, and Npar = 16) and Model-3 (L² = 82.40, p = .53, 
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BIC = 5067.41, AIC = 4963.40 and Npar = 23) appear to be appropriate for further 
analyses (Table 4.10). 
 
Profile of Variables 
 A Wald Test p-value less than .05 was used to determine if all four variables 
contribute in a significant way towards the ability to discriminate between the two 
models. In the following model summary all four variables significantly contribute to the 
prediction of each model as shown in Table 4.11, except for alcohol use in Model-2. In 
Model-2, alcohol use was not significant (Wald = 4.69, p = .096), illegal drug use was 
significant (Wald =11.45, p = .0033), serious depression was significant (Wald = 4.21 p = 
.040) and education was significant (Wald = 7.82, p = .005). In Model-3, alcohol use was 
significant (Wald = 11.36, p = .023), illegal drug use was significant (Wald =22.70, p = 
.0001), serious depression was significant (Wald = 8.61 p = .013) and education was 
significant (Wald = 8.47, p = .014).   
  In an attempt to conclude which model best fits the data, a re-assessment of 
Model-2 and Model-3, using a bootstrap for L², was analyzed to provide a precise 
estimate by relaxing the assumption that the L² statistic follows a chi-square distribution 
(Table 4.12). A repeated re-estimation of parameters resulting from the bootstrap statistic 
indicates the earlier estimates of L² p-value were somewhat overstated for both models.  
Model-2 (p = .008, S.E. = .004) shows a statistically significant difference between what 
the model is predicting and what the data are doing. The bootstrap statistic for Model-3 
(p= .23, S.E. = .018) used to determine goodness-of-fit, concludes that the model fits the 
data.   
 
Bivariate Residuals (BRV) 
 In addition to the previous measures of model fit, another step taken to determine 
the best model for the data is an analysis of the bivariate residuals (BVR). The BVR 
assesses the extent to which the 2-way association(s) between any pair of variables is 
explained by the model. If the model is true, BVRs should not be substantially larger than 
1 and a BVR larger than 2.4 is considered unacceptable (Vermunt & Magidson, 2000). 
As shown in Table 4.13, Model-2 had two BVR values larger than one (education/ illegal  
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Table 4.10  Model Summary   
 
Model Name  BIC (LL) AIC (LL) Npar         L²   df p-value 
Model-1    5089.78      5049.08          9    196.083 98 0.001  
Model-2    5053.14 4980.78     16    113.785 91 0.053 
Model-3    5067.41 4963.40    23      82.404 84 0.53 
Model-4    5106.47 4966.40    30              75.804 77 0.51 
 
 
Table 4.11  Variable Profile   
Variable    Wald Test     p-value  R² (% ) 
 Alcohol Use 
 Model-2        4.69  .096  .2978 (30%) 
 Model-3      11.356  .023  .4219 (42%)   
Illegal Drug Use 
 Model-2      11.45  .0033  .1123 (11.2) 
 Model-3         22.696  .0001    .2376 (24%)   
Serious Depression 
 Model-2        7.822  .005  .0230 (2.3%) 
 Model-3        8.612  .013   .0258 (2.6%) 
Education 
 Model-2        4.214  .040  .0120 (1.2%) 
 Model-3        8.470  .014  .0258 (2.6%) 
   
 
 
Table 4.12  Results from the Bootstrap L²   
 
Model Name   Npar             L²               df           p-value     Bootstrap p-value              S.E.  
Model-2     16      113.785         91            0.053                .008                .0040 
Model-3                   23        82.404         84            0.53                .233                .0188  
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Table 4.13 
Bivariate Residuals   
Model Name   Alcohol Use Illegal Drug Use      Education  Serious Depression 
Model-2 
 Alcohol Use              
  Illegal Drug Use        5.572     
 Education        .2687          1.869 
 Serious Depression    .7083         .8039           .9359 
Model-3     
 Alcohol Use              
  Illegal Drug Use        .0239     
 Education        .7027          .3157 
 Serious Depression    .1995         .4920         1.3920 
 
 
drug and alcohol/illegal drug) and Model-3 had one (serious depression/education). 
Model-2 did have an unacceptable BVR = 5.572 in the 2-way association between  
alcohol and illegal drug, indicating the relationship fails to adequately explain the two 
class model in terms of substance use among the participants. 
  Based on the previous statistical analyses, Model-3 represents a more 
parsimonious model based on a lower AIC, a bootstrap statistic that suggests there is no 
difference between what the model is predicting and what the data are doing and 
acceptable  BVRs for all indicators. Model-3 also provides additional insight as to the 
relationship between the type of substance use and the other study indicators. 
 
Subgroup Classifications 
 To answer the research question pertaining to the size and nature of the three 
subgroups under Model-3, an analysis of conditional probabilities and probability means 
were examined. In Table 4.14, a within group profile is used to illustrate the differences 
in response patterns between the three subgroups. An overview of the analyses shows 
subgroup 1 contains 41% (or 279) of the cases, subgroup 2 contains 33% (or 224 cases) 
and the remaining 26% (or 177 cases) are in subgroup 3. Subgroup 1 reported frequent 
use of alcohol and illegal drugs, most likely to attend some college and experienced less  
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Table 4.14  Within Subgroup Profile Model-3  
   Subgroup 1(%)  Subgroup 2 (%)  Subgroup 3 (%) 
Group Size (%)        40.59 %         33.11%         26.30% 
Alcohol Use 
 No Use        13.59        92.66          61.43 
  15 days       74.30          6.94           2.96  
  16 days       12.11            .40                       35.61 
Illegal Drug Use 
 No Use        20.78           57.54            35.84 
  15 days       66.12                       41.77              1.36 
  16 days       13.10               .69            62.80 
Serious Depression   
 No Depression  85.96  71.33  72.77  
  15 days   2.78    9.60    8.79  
  16 days        11.26                        19.70                        18.44  
Education Levels 
 Grades 1-8        10.90           20.98           14.36 
 Grades 9-12       56.41           60.02                         58.81 
 Some College       31.84           18.72           26.27 
 Some Graduate            .86               .28                .56 
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depression during the last 30 days prior to treatment. Subgroup 2, reported the least use 
of alcohol and illegal drugs, less education and a slightly higher experience with 
depression. Subgroup 3, reported heavy use of both alcohol and illegal drugs, with varied 
educational levels and moderate depression when compared to the other two groups.    
Subgroup Profiles 
  Figure 4.1 provides an overview of Model-3 in relations to the four indicators. 
The two substance use categories (alcohol and illegal drugs) represent the largest 
difference. Subgroup 1 appears to have more education than the other two groups, while 
subgroup 2 indicates higher levels of depression. In Table 4.15, probability means are 
computed using Bayes theorem and are a function of the model’s parameters (estimated 
conditional response probabilities and estimated prevalence of each latent class). Each 
case is assigned to the latent class for which it has the highest (Bayesian) probability of 
membership. In subgroup 1, individuals have over a 90% probability of reporting 1-15 
days of alcohol use, a 65% probability of reporting 1-15 days of illegal drug use, a 50% 
probability of having some college and a 45% probability of reporting no depression in 
the last 30 days prior to treatment. The probability means support study findings that 
suggests individuals reporting frequent substance use in the last 30 days are more likely 
to be in group 1 and individuals reporting heavy substance use are more likely to be in 
group 3, while those reporting no substance use are most likely to be placed in group 2. 
 
Model Definition 
 The best fitting statistical model in the latent class analysis was one in which the 
overall sample was composed of three (3) subgroups. Model-3 including alcohol use, 
illegal drug use, education level and serious depression was identified as best fitting the 
data. It yielded a lower AIC, goodness of fit statistics that support the model predicts 
what the data are doing, acceptable BVRs and provided the simplest solution that 
sufficiently distinguished groups to permit theoretically meaningfully interpretations. The 
three-class model is best defined in conditional probability terms for the four indicators 
items, with substance use being the identifying attributes that stand out for each class. 
The largest group, Subgroup 1, composed of high probabilities to be frequent substance 
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Figure 4.1 Profile Plot Model-3 
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Table 4.15  Across Group Probability Means for Model-3    
 
        Subgroup 1     Subgroup 2               Subgroup 3 
 
Alcohol Use 
 No Use            10%          59%                      31% 
  15 days           91%           7%          2%          
  16 days           34%            1%         65% 
Illegal Drug Use 
 No Use 23% 52% 25%   
  15 days            65%                       34%            1% 
  16 days            24%                                   1%                                   75%     
Serious Depression 
 No Depression     45%          30%          25%        
  15 days             22%                        45%                                   33%         
  16 days             25%           42%          33%   
Education Levels 
 Grades 1-8              28%          48%          24%         
 Grades 9-12             39%                        33%          28%   
 Some College             50%           26%          24% 
 Some Graduate              34%                          1%                                   65% 
 
*across group response patterns  
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 users with less reported depression. In comparison, Subgroup 3 composed of high 
probabilities to be heavy substance users with varying degrees of depression, whereas 
Subgroup 2 had high probabilities of reporting no substance use, but high probability of 
experiencing serious depression within the past 30 days. As shown in Figure 4.2 Model-3 
is best described as, Subgroup 1 being “frequent users/low depression/well educated”, 
Subgroup 2 “low-users/high depression/less educated” and Subgroup 3 as “heavy 
users/moderate depression/educated”. In Figure 1 and Table 4.15, the 3 subgroups 
appear to indicate that substance use is not necessarily a predictor for depression or a lack 
of education. The opposite is true for the following model, with subgroup 2 reporting the 
least substance use and education while reporting experiencing more days of serious 
depression during the last 30 days. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.2 Model-3 
Co-Occurring 
Consumers Presenting for 
Outpatient Treatment 
N = 680 
 
Subgroup 1: Frequent Users 
Low Depression 
Well Educated 
n = 279, (41%) 
Subgroup 2: Low Users 
High Depression 
Less Educated 
n = 224, (33%) 
 
 
Subgroup 3: Heavy Users 
Moderate Depression 
Educated 
n = 177, (26%) 
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CHAPTER V 
SUMMARY AND DISCUSSION 
 
Introduction 
 The purpose of this investigation was to answer the primary research questions, 
“Do distinct homogeneous subgroups exist in a sample of individuals with co-occurring 
disorders presenting for outpatient treatment and if so, how many” and “How well does 
the model fit the data?” The results of the study suggest a parsimonious model that 
supports the existence of three subgroups within the sample. The long-term research goal 
embedded in this initial investigation is to gather empirical evidence that homogeneous 
groups exist within the population diagnosed with co-occurring disorders. The current 
research introduces an exploratory design in which to determine if homogeneous 
subgroups based on latent variables, instead of predetermined indicators, exist. Direct 
empirical evidence, supporting the existence as to whether homogeneous subgroups, will 
significantly improve the usefulness and meaningfulness of group membership as we 
research on antecedents, outcomes, and evidence-based treatment programs continues.  
 The secondary research questions, “What are the size and nature of the 
subgroups?” and “What are the psychosocial variables associated with the subgroups?” 
are answered and discussed in the following section. As shown in previous literature and 
research, frequency of substance use and mental health problems are important indicators 
for diagnosing and treatment planning for co-occurring disorders (Mueser, et al. 1990, 
1992; Reiger et al. 1990; Lehman et al. 1994; Mueser et al. 2000). In the current study 
substance use and depression are both used, along with education, to describe 
membership characteristics within each latent subgroup. This chapter presents a summary 
and discussion of the study’s results for each of the research questions, a consideration of 
the study implications of the findings, study limitations, and recommended future 
directions involving the importance of empirically based co-occurring subgroups. 
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Model Prediction 
 To answer the primary research questions, multiple statistical tests and 
recoding of the data were required to determine if subgroups existed, and if so, how 
many subgroups would make up the most parsimonious model. A goodness-of-fit 
statistic, alternative goodness-of-fit index BIC, number of parameters, conditional 
bootstrap statistic an examination of the bivariate residuals were all employed to 
answer the primary research questions. Goals of latent class analysis are to determine 
significance of indicators within each subgroup, test how well the proposed models 
explain the data and analysis the smallest number of latent classes that adequately 
describes the association among indicators.  
 Current research findings are consistent with Ries and Miller (1993), Lehman et 
al, (1994), and Luke’s (1996) assertion that substance use and mental health are 
important indicators in a systematic approach for classifying subgroups within the 
context of co-occurring disorders. Results of substance use, reported in the current study, 
support earlier research findings that alcohol is the most common type of substance 
reported. Study participants differed from those in other study settings, in that cocaine 
use was the second highest reported substance instead of marijuana and women reported 
higher use of cocaine than men.  In part this could be attributed to the recent increase in 
crack-cocaine. According to the Tennessee Drug Threat Assessment Report (May 2002) 
cocaine use in the state of Tennessee rose over 30% since 1997 to 2000. Another 
unexpected finding was the relationship between alcohol use and age. These results 
suggest that the curvilinear relationship between alcohol use and age, that higher alcohol 
use occurs among younger and older age brackets, is less likely to occur with an 
outpatient population when compared to an inpatient population (Mueser et al., 1992, 
1997, 2001).  
 Comparing the current 3-Class Latent Model with previous models, several 
considerations must be made before discussion. Most comparative studies have been 
conducted on inpatient populations limited to the Northeast region of the United States 
and in treatment settings ranging from psychiatric hospitals, Veterans Administration, 
hospital based residential programs, therapeutic environments, jails/prisons, homeless 
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shelters, and few have been conducted on outpatient populations. Ries and Miller’s 
(1993) 4-Cell Model, later revised by NASMPHD & NASADAD (1999) is the 
conceptual framework for delineating subgroups within the co-occurring population. The 
4-Cell Model has four quadrants based on severity of psychiatric symptomology and 
substance use. Each quadrant is based on problem severity that implies a continuum from 
less severe to more severe psychiatric and substance disorders. The assumption of the 
model suggest individuals seeking outpatient services are more likely to score lower on 
psychiatric symptomology and substance use than individuals presenting for inpatient 
treatment programs. The current 3-Class Latent Model differs from the 4-Cell Model, in 
that the lowest cell in Ries and Miller’s model (Quadrant I) ‘less severe mental 
disorder/less severe substance use disorder” is not represented in the current model. 
Individuals in this classification, under Ries’ model, have yet to seek treatment for their 
co-occurring disorder. Another difference between the two models suggest individuals in 
class 2 of the 3-Class Model were more likely to report higher levels of serious 
depression when compared to Ries’ comparable class (Quadrant 2).  
 An essential step in latent class analysis is to determine if there is local 
independence between latent variables. Latent variables represent response patterns 
within each class or subgroup. For local independence to occur, all latent variables must 
be independent within and across all groups. Local dependence occurs when indicators 
and not independent, causing an overlap between response patterns and thereby effecting 
the latent variables to become dependent. The original research design included variables 
on anxiety, lack of concentration, hallucinations, controlling a violent temper, suicidal 
thoughts and side effects associated with prescription medication. Each indicator, 
independent of the other, was deemed insignificant in determining model prediction.  
Several attempts were made to combine some/all of the indicators into one variable 
measuring mental health, but all results ended in a non-significant p-value. This can also 
be said for other indicators including arrest, days spent in jail, housing, employment, 
family support and income. The insignificant variables violated the assumption of latent 
class analysis, in that they were not independent within or across each class and were 
eliminated from the analysis. 
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 As seen in previous studies on co-occurring disorders, the consensus among 
researchers suggests multiple indicators are needed to best describe existing subgroups 
within the population. However, few researchers agree on which variables are most 
important, and in what setting. By assigning individuals to predetermined diagnostic 
subgroups, based on service patterns (Kessler, et al. 1999), or by defining their main 
substance of use (Miles, et al. 20030), functional abilities (Luke et al. 1996), diagnosis 
(Lehman, et al. 1994) or by examining the relationship between consumer characteristics 
and their lifetime substance use, researchers fail to look for patterns that may occur 
naturally and overlook unexpected or potentially meaningful results. The lack of direct 
empirical research on the heterogeneity of co-occurring disorders not only interferes with 
a deeper understanding of the population but can lead to inaccurate assumptions. Taking 
into account only four indicators were identified as significant in predicting a 
parsimonious model for the current study, the question of which indicators may be more 
important in the early stages of exploration rather than the actual number of variables to 
be studied. An empirical approach to identify latent homogeneous subgroups, instead of 
relying on arbitrarily structured or predetermined subgroups, will provide a systematic 
method in which researchers can test assumptions, determine the most important 
indicators for different treatment settings and begin to replicate research findings for the 
purpose of evidenced-based programs. 
 
Subgroup (Class) Membership 
 To answer the study’s secondary research questions on the nature and correlates 
associated with subgroup membership, a recap of the subgroups is presented. The model 
identified in the study supported three classes: Class I “frequent users/low 
depression/well educated”, Class 2 “low-users/high depression/less educated” and Class 
3 as “heavy users/moderate depression/educated” (Figure 1).  Differences between 
membership characteristics among the three classes support the research’s secondary 
hypothesis that distinct subgroups exist among adults with co-occurring disorders 
presenting for outpatient treatment. Most significant, are the findings that corroborate 
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existing research that substance use and mental health are primary indicators when 
describing the population (Ries et al., 1993; Lehman et al., 1994; Luke et al., 1996).  
In the current study similar classifications are made based on substance use and level of 
depression. It is important to note the depression indicator was the only mental health 
indicator in the current study deemed significant, all other indicators measuring mental 
health were considered insignificant ( .5) in predicting a model. This suggests there may 
not be enough information collected on the mental health indicators to reliably 
distinguish membership between subgroups based on levels on mental health 
symptomology. To a larger extent, the high levels of missing data (above 50%) for the 
mental health indicator limits the study’s ability to explain relationships and make 
inferences between and among the subgroups.  
 Overall study findings, based on available data, on group membership suggests a 
strong association between the use of alcohol, and illegal drugs in all three subgroups. 
Individuals reporting alcohol use, 30 days prior to presenting for treatment, were more 
likely to report similar use of illegal drugs for the same time period.  Frequent users 
reporting  15 days of alcohol use, were more likely to report using illegal drugs for  15 
days. Heavy users followed the same pattern of reporting heavy use (16 days) for both 
alcohol and illegal drugs. A similar response pattern is also true for participants reporting 
low substance use (subgroup 2) for both alcohol and illegal drugs. An alarming finding of 
the substance use analysis is illegal drug use is more likely to be reported in subgroup 2, 
among low users, than the use of alcohol.   
 When examining depression and how it relates to substance use/frequency of use, 
results indicate that participants reported their substance use indiscriminately. Frequent 
users ( 15 days) were likely to be bothered by serious depression (47%) the least among 
the three groups, while the heaviest users (16 days) were likely to report only moderate 
disturbance with serious depression (66%). The unexpected findings of the analysis 
between substance use and depression, was the high likelihood (87%) of group 2 (low 
users) on reporting being bothered by serious depression during the last the 30 days. The 
differences between the subgroups use of substance and depression indicate a trend that 
substance use is secondary to serious depression. The finding provides ancillary evidence 
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that a common misconception exist among service providers that consumers with co-
occurring disorders tend to self-medicate their psychiatric symptoms. These findings give 
credence to the theory that consumers are more likely to use substances to alleviate 
emotional feelings, but not to self-medicate symptoms of psychiatric symptoms such as 
serious depression (Minkoff, 2001; Mueser et al., 1998). The results of this analysis 
imply that substance abuse programs can be an important first contact in primary 
prevention and treatment of mental disorder symptomology. These results contribute to 
the current body of literature that all consumers who present for treatment with either 
disorder should include screening and assessment for co-occurring disorders.  
 Additional descriptive statistics conducted on education and substance use 
suggest individuals with higher levels of education are more likely to report substance 
use in the past 30 days when presenting for treatment. Participants obtaining some 
college were more likely to report alcohol use (54%) when compared to those receiving 
8th grade educations (40%) or participants receiving a 9th -12th  (47%). Individuals 
reporting a 9 -12th grade education were more likely to report illegal drug use for the 
same period. Interestingly, individuals with 8th grade educations were more likely to 
report using alcohol  16 days within the past 30 days but are less likely to report serious 
depression. 
 In summary, study results extend knowledge about individuals with co-occurring 
disorders who are entering an outpatient program while also presenting support to the 
hypotheses that homogenous groups exist in the sample. Overall findings suggest group 
membership is consistent with the general assumptions that substance abuse and mental 
health are important determinates that should be considered when exploring the 
heterogeneity of co-occurring disorders (Minkoff, 2001; NASMPHD & NASADAD, 
1999).   Missing information and the assumptions surrounding the missing data on mental 
health problems 30 days prior to presenting for treatment, may suggest that the 
prevalence of probable mental health disorders among consumers entering outpatient co-
occurring programs have yet to manifest.  
 
  79 
Clinical Significance 
 The clinical significance of this study focus’ on acknowledging the uniqueness of 
this population and our clinical responsibility in knowing consumers as persons. The 
multifaceted complexity of co-occurring disorders and an individual’s response to these 
disorders demands tailored interventions to meet their diverse needs. Implicit in this 
exploration of heterogeneity is also an expectation of an optimal level of care. This study 
seeks to provide a theoretical justification for the need to better understand the population 
through the use of innovative methodological approaches. 
 The current study begins to dispel the notion that the population is best described 
in terms of a hierarchical structure denoted by an increase in problem severity or 
symptomology (Ries et al., 1993; NASMHPD & NASADAD, 1999; Lehman et at., 1994; 
Lehman, et al., 2000; Luke et al., 1996; Mueser et al., 2000; Mueser et al., 2001).  The 
hypothesis supporting a hierarchical order in co-occurring disorders is not supported with 
these findings, specifically as it relates to increased substance use and mental health 
problems. With regard to appropriately diagnosing co-occurring disorders, it is premature 
to propose a substitution for the current diagnostic approach; but as Lehman (2000) 
suggested, “Do certain patterns of co-occurrence pose especially high risk for 
misdiagnosis?  If so, would we not begin to look closer at individuals presenting for the 
first time to an outpatient program.  Likewise, these consumers may engage in outpatient 
treatment settings more easily, even though their focus may be only on their substance 
use. This in mind, outpatient service providers should be cognizant of the potential 
misdiagnoses and underreporting of mental illnesses among this population.  
 The clinical findings suggests, to a large extent, participants in the study did not 
answer questions pertaining to mental health problems, other than serious depression, or 
treatment services received within the last 30 days. These omissions could be interpreted 
as “not applicable” answers that may suggest that consumers presenting at an outpatient 
program currently suffer less from psychological disturbances than their substance use. 
Additionally, consumers seeking outpatient programs with less severe co-occurring 
disorders may present to programs they assume to be more focused on substance abuse 
treatment, rather than mental health treatment. Regardless, all consumers entering the 
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outpatient program in this study reported a lifetime of either substance abuse or mental 
health problems. 
 Another plausible explanation for the large missing data for mental health, may 
exit within the less definitive “co-occurring” term itself.  In considering the results from 
this outpatient population and their limited responses to being “bothered” by symptoms 
commonly associated with mental illnesses, they present as less clear candidates for co-
occurring disorders. More importantly, how can we be sure the sample was representative 
of individuals with co-occurring disorders?  There is no disputing literature that indicates 
mentally ill consumers are at high risk for substance abuse and substance abusers are at 
high risk for mental illness (Lehman et al., 2000; Mueser et al., 2000; Drake et al., 2001; 
Minkoff et al., 2003), but when does the risk become an appropriate diagnoses for a co-
occurring disorder? The current findings support literature suggesting that a thorough 
assessment be given at baseline and continued over treatment because the various 
combinations of these disorders manifest differently over time (Drake, et al., 2001). At 
times symptoms can overlap, interact, and even mask each other making early diagnosis 
difficult. The study sample did receive a thorough assessment at baseline and a diagnosis 
of co-occurring disorder was given to all participants prior to treatment. 
  An important clinical implication resulting from the study, regardless of reported 
symptoms, is the need to conduct routine assessments for all consumers to accurately 
determine diagnosis and treatment. Initial assessments are often presumptive because 
neither disorder may be present at baseline or the consumer is in a state of 
decompensation causing self-report to be less reliable. Similarly, the presence of one 
disorder should not preclude treatment for the other. Moreover, multiple screening tools 
for both substance abuse and mental health problems should be included in the initial and 
subsequent assessments.     
  Despite the limited empirical data available on the heterogeneity and integrated 
treatment interventions for co-occurring disorders, both approaches offer a wide range of 
strategies from which to explore predictive treatment models. To be able to provide 
consumers with optimal care for both disorders, we need to develop a means of 
characterizing the heterogeneous nature of the population before we can predict treatment 
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models with tailored interventions. The current 3-Class Model suggest 3 separate locus of 
care strategies associated with integrated care. In subgroup 1 (frequent users/low 
depression/well educated), respondents might best benefit from individual or group  
intervention outcomes focused on limiting use (harm reduction), family counseling, 
prevention, education and motivational interviewing and/or brief intervention therapy. 
Group 2 (low-users/high depression/less educated) respondents should receive an in-
depth psychiatric evaluation as part of their initial assessment to determine the need for a 
psychopharmacologic treatment regime.  Psychiatric stabilization will be essential to their 
engagement and retention in an outpatient program. Consumers in group 2 will most 
likely benefit from a more individualized treatment program of case management, 
individual therapy, a longer period of continuing care, frequent assessments and 
screening for problem symptomology, psychosocial functioning and substance use. The 
third group (heavy users/moderate depression/educated) may benefit most from a 
comprehensive integrated treatment approach utilizing stage-specific interventions. Stage 
specific interventions personalized to meet the consumer’s willingness to change. Group 
3 respondents should be engaged in on-going active treatment (utilizing various 
integrated treatment components mentioned above), as well as including multiple support 
groups for recovery, rehabilitation and relapse prevention.   
  
Study Implications 
 The current study offers a new way at looking at data to define groups within a 
population by using a probabilistic model approach that allows patterns of association to 
emerge. Exploring data structure instead of artificially constructing it, we gain a deeper 
understanding of the unobservable nuances of a population. Past studies have overlooked 
the concurrent and predictive validity of parameters on group structure, rendering their 
findings questionable. In a latent class analysis, the first step is to conduct a significance 
test on indicators (Table 4.7). Determining their significance in a multivariate data set 
allows the researcher to make important assumptions about subgroup membership 
characteristics.  
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 Given the exploratory nature of latent class analysis and the need to identify 
underlying psychosocial factors that govern overt behaviors, social researchers should re-
evaluate their current statistical methods. Earlier observational studies on the 
heterogeneity of co-occurring disorders restricted our ability to fully explore unobserved 
variables, potentially overstating associations, bias observation towards the null, and 
underestimate dependency between indicators. Latent class analysis is a robust and 
powerful tool to approach classification techniques and modeling. Moreover, latent class 
analysis does not presuppose normal distributions, linear relationships or 
continuous/interval measurement levels like other methodologies. Needless to say, latent 
class analysis has some practical problems, addressed under study limitations, but the 
possibilities offered add theoretical value to systematic research approaches.  
 The premise of this model suggests subgroups within an outpatient treatment 
setting can be distinctly different and such differences can be used to develop meaningful 
and effective treatment programs. An integrated care treatment approach has shown 
advances and success in treating this complex population through a host of therapeutic 
strategies. By identifying homogeneous subgroups within the population and matching 
these subgroups to appropriate elements of integrated care, in theory, provides new 
research opportunities to explore predictive modeling. Clinical benefits in predictive 
modeling facilitate evidence-based programs and promote delivery and access to 
effective services. This research to practice approach translates, not only into therapeutic 
relevance by providing appropriate care, but for prevention, diagnosing, and long-term 
care management.  
 Argued earlier in this paper, co-occurring disorders are best described in chronic 
illness terms. Disease management is a promising managed care strategy that has 
empirical evidence of improving care and reducing cost associated with chronic illnesses 
(Kongstvedt, (1996).  The need to identify co-occurring subgroups that hold therapeutic 
relevance is the same framework instituted by the medical field and implemented under 
the clinical strategy of disease management. Healthcare service providers understand the 
need to implement and improve treatment settings based on long-term stabilization. 
Ideally, treatment intensity is dictated by problem severity and at a lesser degree trained 
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staff and local treatment resources. The latter is “the” reality for individuals diagnosed 
with co-occurring disorders. Consequently, attempting to provide appropriate care is the 
primary aim among co-occurring service providers, but the complexity of the population 
makes it difficult for providers to be responsive to their unique service needs. 
Classification schemes and prospective long-term care plans have positive implications 
for both the consumer and the provider. From a conceptual viewpoint the more healthcare 
providers can differentiate among consumers, the less dependent they become on 
diagnosis and more focused on treatment. 
 Identifying mutually exclusive subgroups, like those found in managed care, is 
based on the premise that the level of resources necessary for delivering quality of care is 
directly correlated with knowing and understanding the multiple domains of an 
illness/disease. With the acceleration of managed care strategies into the public sector, 
behavioral programs will be expected to impose stricter organization, controls, quality 
measurement and accountability on the delivery of services. Through research, similar to 
the current study, empirical data is needed to better understand and serve complex 
populations. As in managed care, behavioral healthcare must show quality and 
effectiveness of care delivered by programs through the use of clinical outcome 
measures, define a common system of cost accounting for both disorders and monitor 
data carefully to emphasis collaboration and not cost shifting. Behavioral medicine 
providers have been remiss in implementing research findings into practice and creating 
evidence-based programs and outcomes for the co-occurring population (SAMHSA, 
2000). Without collaborative commitment between researchers and practitioners little 
will change in healthcare policy as it relates to co-occurring disorders. More importantly, 
success for behavioral providers not only relies on improved communications between 
practitioner and researcher, but systems management infrastructures are needed to 
implement and monitor evidence-based programs. Managed care initiatives may continue 
to be debated on its strengths and weaknesses, but little debate is required over the 
success of its systems integration capabilities. Current behavioral health systems consider 
systems integration as a composite of interagency referral patterns, information sharing 
and funding relationships instead of advance technology.   
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 In terms of healthcare policy, behavioral health providers are unprepared to meet 
the challenges of implementing and managing evidence-based programs demanded by 
government funding agencies (SAMHSA, 2000). Co-occurring service providers have 
focused much of their time on meeting the wide range of social and rehabilitative support 
service needs of the public sector and less on infrastructure, access and prevention. The 
time is here to shore up support among the medical field and policy makers to create 
available funding to build sound infrastructures for the nation’s behavioral healthcare 
system. Behavioral service providers need to work closely with the National Council for 
Community Behavioral Healthcare on developing proactive legislation to address 
prevention as well as expand treatment dollars for co-occurring disorders. Prevention 
policies must become standard in behavioral healthcare with an emphasis on promoting 
wellness rather than treating the illness associated with mental and substance abuse 
disorders. Another policy area of contention is the Mental Health Parity Act of 2007, 
which recently passed in the Congress. The Act has made great strides since its 
conception in 1996, but falls short of mandating group health plans to provide mental 
health and substance abuse treatment to their insured. Instead health plans that choose to 
offer mental health and substance abuse treatment are required to offer only parity. The 
contentious piece of the parity debate is fueled by private payers such as insurance 
companies and large self-insured companies insisting that behavioral health organizations 
have not produced evidence-based data relating to the effectiveness of their programs, in 
particular outpatient programs (Barry, 2006).  
  
Study Limitations 
 The central limitation of the study is the archival data are collected for reasons 
other than for the present research objectives. The primary objective in collecting the 
original data, over a one-year period at three separate intervals, was to determine the 
effectiveness of an outpatient program and not to determine if homogeneous subgroups 
existed in the sample. Regarding the original data collected by means of the GPRA, 
several challenges were presented early in the modeling process that resulted in the 
elimination of multiple indicators. Latent class analysis can handle multivariate 
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(categorical/ordinal) data easily but less so if there are a large number of response 
patterns causing sparse frequency tables. Sparseness takes place when there are a large 
number of indicators and each indicator has multiple response categories. The problem 
occurs when there are large scale response patterns (trends) among the variables, causing 
the data to appear sparse in meaningful information. 
  The most important limitations to the study was the exclusion of all, but one, 
mental health indicator due to missing information ( 68%) and the manipulation of the 
data to determine a model. It can be said that different decisions in the handling of the 
missing data and preparation of the variables necessary for estimating a model, would 
have resulted in a different model. This suggest when observed data are incomplete, the 
missing data can add uncertainty to group membership and the overall model. It also 
suggests that research bias enters into the recoding and recomputing of variables. 
Furthermore, it is possible that the current model understates the prevalence of mental 
health symptoms and may fall short of accurately explaining the relationship among 
multiple variables in the sample of individuals with co-occurring disorders entering an 
outpatient program. 
 Local independence is a basic assumption in latent class analysis that all study 
(observed) variables are independent within each latent class. Local independence 
implies the latent variable (unique response pattern) fully accounts for the association 
between the observed and expected variables. A simple Wald statistic can be used to 
identify if an indicator is significant in determining the model.  Essentially, insignificant 
variables lead to local dependence and render the model meaningless. To identify which 
variables are dependent upon each other, the researcher must manually explore all 
insignificant variables through a trial and error process. The process involves starting 
with a basic assumption as to which variables are dependent and which ones are most 
important to the overall model.  When dependency is determined, joint variables are 
created to re-estimate the model. Concerns with this process include the heuristic nature 
of determining dependency; secondly, there are no criteria for making the trade-off 
between creating joint variables to eliminate insignificant and/or dependent variables 
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which may increase the noise within a latent variable versus completely eliminating the 
insignificant variables from the potential model (Huang, 2005).  
 Local maxima is a major concern that needs to be considered anytime an 
optimization technique sets out to find the global maxima or the best fit of a model to the 
data. Local maxima are a numerical procedure that provides optimal performance in 
producing a model by taking into consideration only a portion of the data at a given 
staring point. To find the best fit, the EM algorithm continually searches for the best 
“global” fit by using an iteration process with different starting values. Using different 
starting values can lead to unstable or inconsistent modeling results. A technical option, 
not necessarily a solution, is to generate a larger set of random starting values (iteration) 
and compare the results of each starting value. If the results converge, it is likely global 
maxima has been obtained. If results continue to be unstable, there is strong likelihood 
the data table holds a large number of relatively low frequency counts (sparseness). In the 
event of sparseness, the system assigns a non-probability value of zero to parameters. 
Identifying the parameters that have no probability value can be a lengthy exploration. 
When identified they can be removed but with some cost. In a probabilistic environment, 
like latent class analysis, removing parameters considered to be erroneous can potentially 
change the scalability of the data and the model outcome. The best solution is to identify 
steps that minimize the possibility of local maxima (data sparseness) occurring (Vermunt 
et al., 2000; Huang, 2005,).  
     
Future Directions 
  The central recommendation is to move rapidly to exploratory analysis to identify 
and understand homogeneous subgroups within the co-occurring population in order to 
facilitate the development of subgroup specific evidence-based interventions and their 
adoption into treatment programs. It is time to move away from “mere description” of 
heterogeneity in narrow or arbitrarily structured terms and toward rigorous scientific 
exploration. More critically, latent class analysis provides a new and relatively flexible 
methodological approach that contributes in identifying empirically defined subgroups. 
Latent class analysis is an emerging model-based clustering approach in psychosocial 
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analysis of categorical and/or ordinal data without imposing a priori assumption of 
grouping variables or number of groups. Researchers along with practitioners should 
work collaboratively to develop and incorporate shared decision-making standards when 
using cluster-based modeling approaches. When decision-making standards are adopted 
and systematically implemented and subgroups are well-defined, new research questions 
should focus on how best to use these groups for treatment planning, creating care 
management and evidence-based programs.  
 Meanwhile, additional latent class analysis research needs to include multi-site 
studies conducted in various treatment settings among a variety of co-occurring 
populations, and gender based studies. In future LCA research, researchers must 
understand the potential barriers associated with missing data, local dependence, local 
maxima and insignificant indicators in order to appropriately guide future studies. In 
utilizing archival data, the researcher must put emphasis on item quality to ensure 
accurate and unbiased estimates of the latent class model parameters. In addition, 
tremendous progress has been achieved in the recognition and treatment of co-occurring 
disorders but additional research topics should include the need to better understand the 
trajectory of the illness from socio-environmental and other non-biological factors as well 
as psychosocial. 
 From a systems perspective, behavioral healthcare providers under the current 
bifurcated delivery system are not providing the necessary link between the use of 
services and illness control and outcomes. Behavioral health systems continue to function 
under an acute care model when treating chronic illnesses like co-occurring disorders. A 
fundamental directional change needs to occur within the delivery system to adopt 
strategies that have proven successful under managed care. Priorities include 
implementing a long-term care perspective, building strong infrastructures to support the 
technology and outcome demands of evidence-based programs, rigorous and systematic 
research standards and advocacy efforts to support local and federal funding for 
integrated treatment practices at all levels. Consequently, adopting certain tenets of 
managed care initiatives must also encompass the systems mission, philosophy, 
governance, and quality management with regard behavioral medicine.  
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FOUR GENERAL MODELS  
OF CO-OCCURRING DISORDERS 
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Table A.1  
 
Four General Models of Co-occurring Disorders. (Anthony, 1991; Kosten & Ziedonis, 
1997; Kushner & Mueser, 1993; Weiss & Collins, 1992) (See Appendix A). 
 
 
  Model    Description and Examples 
 
Common Factor High rates of co-morbidity are the result of risk factors shared across both  
 severe mental illness and substance abuse disorders 
 
Secondary Substance    Severe mental illness increases a person’s chances of developing a substance 
Abuse Disorder abuse disorder 
 
Secondary Mental &  Substance abuse precipitates severe mental illness in people who would not  
Psychiatric Disorder    otherwise develop a severe mental illness. 
 
 
Bi-directional     Either severe mental illness or substance abuse disorders can increase a  
    person’s vulnerability to developing the other disorder. 
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Table B.1  
 
SAMHSA, Managed Care Initiatives for Co-Occurring Disorders  
 
 
Initiatives     Strategies 
    
Policy   Emphasize the importance of co-occurring disorders as a national policy. 
Develop standard language on co-occurring disorders. 
Stimulate system collaborations at the State level. 
Convene federal stakeholders to establish a research agenda. 
 
Prevention  Develop a national strategy on prevention   
   Incorporate drug prevention and education efforts in all service programs. 
Consumer assessments should include determination of family histories 
 
Assess    Promote integration of mental health and substance abuse treatment services.  
Promote and train multidisciplinary team.  
Provide relative and sensitive treatments across culture, ethnicity, and gender. 
Develop and maintain a long-term perspective to treatment. 
 
Quality   Foster professional education on co-occurring disorders.  
Refine assessment and identification of co-occurring measurement tools. 
Foster treatment specificity, flexible and individualized treatment plans 
    
Evaluation Develop relapse and maintenance criterion as inherent in co-occurring disorders. 
Recognize that principles and best practices should change with new knowledge. 
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APPENDIX C 
 
THE NATIONAL ASSOCIATION OF STATE  
MENTAL HEALTH PROGRAM DIRECTORS’  
AND NATIONAL ASSOCIATION OF STATE  
ALCOHOL AND DRUG ABUSE DIRECTOR’S 
 MODEL OF THE UNIVERSE OF  
CO-OCCURRING DISORDERS 
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   Service Coordination by Severity 
Quadrant III 
 
Locus of Care 
Substance Abuse System 
*Less severe mental disorder/more 
severe SA disorder 
Quadrant IV 
 
Locus of Care 
 State Hospitals, Jails/Prisons, 
Emergency Rooms,   
*More severe mental 
disorder/more severe SA 
disorder 
 Quadrant I 
 
Locus of Care 
Primary Health Care Settings 
* Less severe mental disorder/less 
severe SA disorder 
Quadrant II 
  
Locus of Care 
Mental Health System 
* More severe mental 
disorder/less severe SA disorder 
 
      
 
Figure C.1  
 
The National Association of State Mental Health Program Directors’ and National 
Association of State Alcohol and Drug Abuse Directors’ Model of the Universe of Co-
Occurring Disorders. 
 Low 
 High 
 Low 
  111 
 
 
 
 
 
APPENDIX D 
 
LEHMAN’S SUBGROUPS (1994) 
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Table D.1  
 
Lehman’s Subgroups (1994) 
 
 
Subgroups  Lehman’s 10 Subgroup Definitions    n=  
     
Group I   Definite dual diagnosis; current.    109 
       Group II   Possible dual diagnosis; current.       71 
       Group III  Substance induced organic; current.     74 
       Group IV  Definite dual diagnosis: not current.     78 
       Group V  Independent mental disorder: current.     89 
       Group VI   Substance abuse disorder only, current.     40         
               N =  461 
 
Group VII  Substance-induced organic mental disorder, past.    6  
Group VIII   Independent mental disorder only, past.     0 
Group IX   Substance abuse disorder only, past.     1 
Group X   No disorder.        0 
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LEHMAN’S CLUSTER GROUPS  
(DSM-IV Diagnostic Groupings) 
  114 
 
 
 
  
 
Table E.1 
 
Lehman’s Cluster Groups. (DSM-IV Diagnostic Groupings) 
 
  
      DSM-IV Diagnosis Groupings                 
 
Cluster A  Paranoid, schizoid, and schizotypal personality disorders. 
  
Cluster B Anti-social, borderline, histrionic, narcissistic personality disorders 
 
Cluster C avoidant, dependent, obsessive-compulsive, & passive-aggressive personality 
disorders and personality disorders not otherwise specified.  
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Form Approved 
OMB No. 0930-0208 
Expiration Date 12/31/2005 
 
 
 
 
 
 
CSAT GPRA Client Outcome  
Measures for Discretionary Programs 
 
 
 
 
 
 
 
 
            
 
 
 
 
 
 
 
 
 
 
 
Public reporting burden for this collection of information is estimated to average 20 minutes per 
response if all items are asked of a client/participant; to the extent that providers already obtain 
much of this information as part of their ongoing client/participant intake or followup, less time 
will be required.  Send comments regarding this burden estimate or any other aspect of this 
collection of information to SAMHSA Reports Clearance Officer, Room 16-105, 5600 Fishers 
Lane, Rockville, MD 20857.  An agency may not conduct or sponsor, and a person is not required 
to respond to a collection of information unless it displays a currently valid OMB control number.  
The control number for this project is 0930-0208. 
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A. RECORD MANAGEMENT 
 
Client ID                |____|____|____|____|____|____|____|____|____|____|____| 
Contract/Grant ID   |____|____|____|____|____|____|____|____|____|____| 
Grant Year    |____|____|____|____| 
     Year 
Interview Date  |____|____| / |____|____| / |____|____|____|____| 
   
Interview Type 
1.  Intake 2. 6 month follow-up 3. 12 month 
follow-up 4. 3 month follow-up 
 
Service Type  
For intake interview: What service type will the client receive in your program?  
(Check all  
that apply.) 
_____ 1.  Case Management  
_____ 2.  Day Treatment 
_____ 3.  Inpatient 
_____ 4.  Outpatient 
_____ 5.  Outreach 
_____ 6.  Intensive Outpatient 
_____ 7.  Methadone 
_____ 8.  Residential 
_____ 9.  Other ____________________ 
_____ 10. Other ____________________ 
_____ 11. Other_____________________ 
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B.   DRUG AND ALCOHOL USE 
1. During the past 30 days how many days have you 
used the following: 
Number of 
Days 
Number of 
Years 
(Lifetime) 
a. Any alcohol  |____|____| |____|____| 
b1. Alcohol to intoxication (5+ drinks in one 
sitting) |____|____| |____|____| 
b2. Alcohol to intoxication (4 or fewer drinks and 
felt high) |____|____| |____|____| 
c. Illegal drugs |____|____| |____|____| 
2. During the past 30 days, how many days have you 
used any of the following: 
Number of 
Days 
Number of 
Years 
(Lifetime) 
a. Cocaine/Crack |_____|____| |_____|____| 
b. Marijuana/Hashish (Pot, Joints, Blunts, 
Chronic, Weed, Mary Jane) 
|_____|____| |_____|____| 
c.  Heroin (Smack, H, Junk, Skag), or other 
opiates:  
1.  Heroin (Smack, H, Junk, Skag) 
2.  Morphine 
3.  Diluadid 
4.  Demerol 
5.  Percocet 
6.  Darvon 
7.  Codeine 
8.  Tylenol 2,3,4 
 
 
|_____|____| 
|_____|____| 
|_____|____| 
|_____|____| 
|_____|____| 
|_____|____| 
|_____|____| 
|_____|____| 
 
 
|_____|____| 
|_____|____| 
|_____|____| 
|_____|____| 
|_____|____| 
|_____|____| 
|_____|____| 
|_____|____| 
d. Non-prescription methadone |____|____| |____|____| 
 
       e.      Hallucinogens/psychedelics, ect… |____|____| |____|____| 
      
g. 1. Benzodiazepines: Diazepam , ect..          
          2. Barbiturates: Mephobarbital, ect. 
          3. Non-prescription GHB  
          4. Ketamine (Special K or  Vitamin K)  
          5. Other tranquilizers, downers, sedatives  
 
  
h. Inhalants (poppers, snappers, rush, whippets) |____|____| |____|____| 
i. Other illegal drugs (specify) 
________________  |____|____| |____|____| 
 
3.  In the past 30 days have you injected drugs?        Yes      No 
 If no, go to Section C. 
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4. In the past 30 days, how often did you use a syringe/needle, cooker, cotton or water 
that someone else used? 
 Always 
 More then half the time 
 Half the time 
 Less then half the time 
 Never 
 
C. FAMILY AND LIVING CONDITIONS 
 
1. In the past 30 days, where have you been living most of the time? 
 
 Shelter (safe havens, TLC, low demand facilities, reception centers, other 
temporary day or evening facility) 
 Street/outdoors (sidewalk, doorway, park, public or abandoned building) 
  Institution (hospital, nursing home, jail/prison) 
  Housed: 
 Own/rent apartment, room, or house 
 Someone else’s apartment, room or house 
 Halfway house 
 Residential treatment 
 Other housed 
(specify)___________________________________  
 
2. During the past 30 days, how stressful have things been for you because of  your use 
of alcohol or other drugs?  
 
  Not at all 
 Somewhat 
Considerably 
 Extremely 
 Not applicable 
 
3. During the past 30 days, has your use of alcohol or other drugs caused you to reduce 
or give up important activities? 
 
  Not at all 
 Somewhat 
 Considerably 
 Extremely 
 Not applicable 
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4. During the past 30 days, has your use of alcohol or other drugs caused you to have 
emotional problems? 
 
  Not at all 
  Somewhat 
  Considerably 
 Extremely 
 Not Applicable 
 
 
D.   EDUCATION, EMPLOYMENT, AND INCOME 
 
1. Are you currently enrolled in school or a job training program?  (IF 
ENROLLED: Is that full time or part time?) 
 
 Not enrolled 
 Enrolled, full time  
 Enrolled, part time 
 Other (specify)______________ 
 
2. What is the highest level of education you have finished, whether or not you 
received a degree?  (01=1st grade, 12=12th grade, 13=college freshman, 16=college 
completion)  
      |____|____| level in years 
 
2a. If less than 12 years of education, do you have a GED (General Equivalency 
Diploma)? 
  Yes    No 
 
3. Are you currently employed? (Clarify by focusing on status during most of the 
previous week, determining whether client worked at all or had a regular job but was 
off work) 
  Employed full time (35+ hours per week, or would have been ) 
  Employed part time 
  Unemployed, looking for work 
  Unemployed, disabled 
  Unemployed, volunteer work 
  Unemployed, retired 
  Unemployed, not looking for work 
  Other (specify) ___________ 
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4. Approximately, how much money did YOU receive (pre-tax individual income) 
in the past 30 days from… 
INCOME  
 
a. Wages 
 
$ 
 
 
 
 
 
 
 
, 
 
 
 
 
 
 
 
.00 
 
b. Public assistance 
 
$ 
 
 
 
 
 
 
 
, 
 
 
 
 
 
 
 
.00 
 
c. Retirement 
 
$ 
 
 
 
 
 
 
 
, 
 
 
 
 
 
 
 
.00 
 
d. Disability 
 
$ 
 
 
 
 
 
 
 
, 
 
 
 
 
 
 
 
.00 
 
e. Non-legal income 
 
$ 
 
 
 
 
 
 
 
, 
 
 
 
 
 
 
 
.00 
 
f. Other (specify) ________________ 
 
$ 
 
 
 
 
 
 
 
, 
 
 
 
 
 
 
 
.00 
 
E.   CRIME AND CRIMINAL JUSTICE STATUS 
 
1. In the past 30 days, how many times have you been arrested? |____|____| times 
If no arrests, go to item E3  
2. In the past 30 days, how many times have you been arrested for drug-related 
              offenses?  |____|____| times 
 
 
 
 
3. In the past 30 days, how many nights  have you spent in jail/prison? |____|____| 
 
 
             |nights  
 
 
 
F.   MENTAL AND PHYSICAL HEALTH PROBLEMS AND 
TREATMENT 
 
1. How would you rate your overall health right now? 
 
 Excellent 
  Very good  
  Good 
  Fair 
  Poor 





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2. During the past 30 days, did you receive: 
 
 a. Inpatient Treatment for:     If yes, altogether 
       No  Yes ± for how many nights 
          (DK=98) 
 i.  Physical complaint        ___________ 
 ii.  Mental or emotional difficulties      ___________ 
 iii.  Alcohol or substance abuse       ___________ 
 
 b. Outpatient Treatment for:     If yes, altogether 
       No  Yes ± how many times 
          (DK=98) 
 i.  Physical complaint        ___________ 
 ii.  Mental or emotional difficulties      ___________ 
 iii.  Alcohol or substance abuse       ___________ 
 
 c. Emergency Room Treatment for:    If yes, altogether 
       No  Yes ± for how many times 
          (DK=98) 
 i.  Physical complaint        ___________ 
 ii.  Mental or emotional difficulties      ___________ 
 iii.  Alcohol or substance abuse       ___________ 
 
3. During the past 30 days, did you engage in sexual activity?  
 Not permitted to ask   Yes   No 
 If yes, altogether How many (DK=98)        
   
a. Sexual contacts (vaginal, oral, or anal) did you have?  |____|____|____| 
b. Unprotected sexual contacts did you have?   |____|____|____| 
c. Unprotected sexual contacts were with an individual who is or was: 
1. HIV positive or has AIDS   |____|____|____| 
2. An injection drug user   |____|____|____| 
3. High on some substance   |____|____|____| 
 
 
4. In the past 30 days (not due to your use of alcohol or drugs) how many days have 
you:  
 
a. Experienced serious depression |____|____| 
b. Experienced serous anxiety or tension |____|____| 
c. Experienced hallucinations |____|____| 
d. Experienced trouble understanding, concentrating, 
    or remembering |____|____| 
e. Experienced trouble controlling violent behavior |____|____| 
f. Attempted suicide |____|____| 
g. Been prescribed medication for psychological/emotional problem |____|____| 
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4a. If you reported one or more days in question 4, how much have you been bothered 
by  
 these psychological or emotional problems in the past 30 days? (If you did not report  
 any days to the items in question 4, skip to the next question.)  
  Not at all 
  Slightly 
  Moderately 
  Considerable 
  Extremely 
 
H. DEMOGRAPHICS (ASKED ONLY AT BASELINE) 
 
1.   Gender 
  Male 
 Female 
 Transgender 
 Other (specify) ________________ 
 
2.   Are you Hispanic or Latino? 
   Yes   No 
 
If yes, what ethnic group do you consider yourself? (CSAT ONLY) 
 Central American 
 Cuban 
 Dominican 
 Mexican 
 Puerto Rican 
 South American 
 Other, specify ___________________________ 
 
3.   What is your race?  (Select one or more) 
  Black or African American   Alaska Native 
 Asian      White  
  American Indian    Other (specify)______________ 
  Native Hawaiian or other   
Pacific Islander  
4. What is your date of birth? |____|____| / |____|____| / |____|____|____|____| 
       Month     /      Day       /      Year 
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I. FOLLOW-UP STATUS  (REPORTED BY PROGRAM STAFF 
ABOUT CLIENT ONLY AT FOLLOW-UP)  
 
1. What is the follow-up status of the client? 
 
 01 = Deceased at time of due date 
 11 = Completed within specified window 
  21 = Located, but refused, unspecified 
  22 = Located, but unable to gain institutional access 
  23 = Located, but otherwise unable to gain access 
  24 = Located, but withdrawn from project 
  31 = Unable to locate, moved 
 32 = Unable to locate, other 
 
 
J. DISCHARGE STATUS (REPORTED BY PROGRAM STAFF 
ABOUT CLIENT ONLY AT FOLLOW-UP) 
 
1. On what date was the client discharged? |____|____| / |____|____| / 
|____|____|____|____| 
Month     /      Day       /      Year 
 
2. What is the client’s discharge status? 
 
 01 = Completion/Graduate 
 02 = Termination 
If the client was terminated, what was the reason for termination? (Select one 
response.) 
 01 = Left on own against staff advice with satisfactory progress 
 02 = Left on own against staff advice without satisfactory progress 
 03 = Involuntarily discharged due to nonparticipation 
 04 = Involuntarily discharged due to violation of  rules 
 05 = Referred to another program or other services with satisfactory 
 06 = Referred to another program or other services with unsatisfactory  
 07 = Incarcerated due to offense committed while in treatment    
 satisfactory progress 
 08 = Incarcerated due to offense committed while in treatment with    
             Unsatisfactory progress 
 09 = Incarcerated due to old warrant or charged from before entering       
              treatment with satisfactory progress 
10 = Incarcerated due to old warrant or charged from before     
 11 = Transferred to another facility for health reasons 
 12 = Death 
 13 = Other 
__________________________________________________________ 
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APPENDIX G 
 
ADDICTION SEVERITY INDEX (ASI) 
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TREATMET SERVICE REVIEW (TSR-5) 
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Name: ___________________________________________ Date: _______________________ 
Interviewer: _______________________________________ Pt. ID #: _____________________ 
Treatment Week #: _________________________________ Program #: __________________ 
Treatment Services Review (2/1/89) 
Please record services (provided or referred) by the treatment program (IN-PROG) separately 
from those provided by other sources (OUT-PROG). 
MEDICAL PROBLEMS How many days in the past week have you: 
1. experienced significant physical medical problems?                        _________ 
        IN-PROG    OUT-PROG   
2. been hospitalized for physical medical problems?   _________ __________ 
3. received medication for a medical problem?    _________ __________ 
How many times in the past week have you: 
4. seen a physician for medical care?     ____/____ ____/____ 
5. seen a nurse, nurse practitioner, or physician's  
assistant for medical care?      ____/____ ____/____ 
6. had a significant discussion pertinent to your medical problems: 
 individual session?      ____/____ ____/____ 
 group session?       ____/____ ____/____ 
EMPLOYMENT AND SUPPORT PROBLEMS:    IN-PROG   OUT-PROG 
1. How many days in the past week have you been paid for working?     _________ 
2. been in school or training?      _________ __________ 
How many times in the past week have you: 
3. seen someone regarding employment opportunities, training or education:  
 employment specialist?      ____/____ ____/____ 
 counselor/social worker?     ____/____ ____/____ 
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4. seen someone regarding unemployment compensation, welfare, social security, housing or 
other income: benefits specialist?     ____/____ ____/____   
 counselor/social worker?    ____/____ ____/____ 
5. had a significant discussion pertinent to your employment/  support problem:  
 individual session?      ____/____ ____/____ 
 group session?       ____/____ ____/____ 
ALCOHOL PROBLEMS: How many days in the past week have you: 
1 . drunk any alcohol?        _________ 
2. drunk any alcohol to the point of intoxication (note definition)?  _________ 
        IN-PROG    OUT-PROG 
3. been in inpatient treatment for an alcohol problem?              _________ __________ 
4. received medication to help you to detoxify from alcohol?  _________ __________ 
5. received medication to prevent you from drinking?   _________ __________ 
6. received a blood alcohol test (e.g., breathalyzer)?   _________ __________ 
How many times in the past week have you: 
7. attended an alcohol education session?    ____/____ ____/____ 
8. attended an AA or 12-step meeting?     ____/____ ____/____ 
9. attended an alcohol relapse prevention meeting?   ____/____ ____/____ 
10. had a significant discussion pertinent to your alcohol problems:  
 individual session?      ____/____ ____/____ 
 group session?       ____/____ ____/____ 
DRUG PROBLEMS:  
How many days in the past week have you:    IN-PROG    OUT-PROG 
1 . used any illicit drug?                 _________ 
2. been in inpatient treatment for a drug problem?   _________ _________ 
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3. received medication to help you detoxify/come off a drug?  _________ __________ 
4. received medication to maintain/stabilize your drug use?  _________ __________ 
5. received medication to block the effects of drugs?   _________ __________ 
6. received a urinalysis, or other test for drug use?   _________ __________ 
How many times in the past week have you: 
7. attended a drug education session?     ____/____ ____/____ 
8. attended a session of NA or CA?    ____/____ ____/____ 
9. attended a drug relapse prevention group or session?   ____/____ ____/____ 
10. had a significant discussion pertinent to your drug problems:  
 individual session?      ____/____ ____/____ 
 group session?       ____/____ ____/____ 
DRUG PROBLEMS: How many days in the past week have you:  
        IN-PROG    OUT-PROG 
1 . used any illicit drug?        ________ 
2. been in inpatient treatment for a drug problem?   _________ __________ 
3. received medication to help you detoxify/come off a drug?  _________ __________ 
4. received medication to maintain/stabilize your drug use? __ _________ ________ 
5. received medication to block the effects of drugs?   _________ __________ 
6. received a urinalysis, or other test for drug use?   _________ __________ 
How many times in the past week have you: 
7. attended a drug education session?     ____/____ ____/____ 
8. attended a session of NA or CA?    ____/____ ____/____ 
9. attended a drug relapse prevention group or session?   ____/____ ____/____ 
10. had a significant discussion pertinent to your drug problems:  
 individual session?      ____/____ ____/____ 
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 group session?      ____/____ ____/____  
 
LEGAL PROBLEMS: How many days in the past week have you:  
1 . been incarcerated?            _________ 
2. engaged in illegal activities for profit?                      _________ 
         IN-PROG  OUT-PROG 
3. the courts, criminal justice system, probation/parole office been  
contacted regarding your legal problem (either by patient or program)?  ____/____ ____/____ 
4. had a significant discussion pertinent to your legal problems: 
  individual session?       ____/____ ____/____ 
 group session?        ____/____ ____/____ 
 
FAMILY PROBLEMS: How many days in the past week have you:  
1 . experienced significant family/social problems?           _________ 
2. experienced significant loneliness and/or boredom?           _________ 
How many times in the past week have you:    IN-PROG  OUT-PROG  
3. had a significant discussion pertinent to your family problems  
 with family present: family specialist?     ____/____ ____/____ 
 counselor/social worker       ____/____ ____/____ 
4. had a significant discussion pertinent to your family problems  
without family present:  
 family specialist?       ____/____ ____/____ 
 counselor/social worker      ____/____ ____/___ 
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PSYCHOLOGICAL / EMOTIONAL PROBLEMS: How many days in the past week have you: 
1. experienced significant emotional problems?      _________ 
         N-PROG OUT-PROG 
2. been hospitalized for an emotional or psychiatric problem?   ____/____ ____/____ 
3. received testing for psychiatric or emotional problems?  ________ __________ 
4. received medication for your psychiatric or emotional problems?_ _______ __________ 
How many times in the past week have you: 
5. received a session in which you practiced a form of relaxation training,  
 biofeedback, or meditation? psych specialist?    ____/____ ____/____ 
 counselor/social worker      ____/____ ____/____ 
6. received a session in which you practiced a form of behavior modification  
(e.g., role play, rehearsal, psychodrama, etc.)  
 psych specialist?       ____/____ ____/____ 
 counselor/social worker       ____/____ ____/____ 
7. had a significant discussion/individual therapy pertinent to your  
psychiatric or emotional problems:  
 psych specialist?       ____/____ ____/____ 
 counselor/social worker      ____/____ ____/____ 
 
 
 
 
 
 
 
 
 
 
     138 
 
 
 
 
 
 
 
APPENDIX I 
 
DUAL DIAGNOSIS MANAGEMENT (DDM)  
DATA RELEASE AGREEMENT 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
     139 
 
DUAL DIAGONSIS MANAGEMENT (DDM): DATA RELEASE AGREEMENT 
 
THIS AGREEMENT is made on the ____________________________ 2006 
 
BETWEEN: Dual Diagnosis Management (DDM) (Operating Data Owner)  acting as Operator for and on 
behalf of itself, Kathleen H. Darby, (Recipient) CMSW, acts for and on behalf of herself. 
 
WHEREAS: 
 
DDM has developed the following Terms and Conditions under which proprietary Data (Substance Abuse 
and Mental Health Service Administration (SAMHSA) Expansion and Enhancement Grant: Outpatient 
Program, T1-12720) shall be released to Kathleen H. Darby. Pursuant to the Terms and Conditions, DDM 
shall make available the Data to Kathleen H. Darby and Kathleen H. Darby agrees to take and use such 
Data, on the terms and conditions herein contained. 
 
Terms and Conditions: 
a) The Data provided to Recipient is for the exclusive purpose for academic research and may not be 
used for any other purposes without the explicit written approval, in advance, Operating Data 
Owner. 
b) The Data is released to Recipient as a working copy for her use only. The distribution, sale, 
donation, transfer, or exchange of any portion of these Data in any way is expressly prohibited. 
This restriction includes sharing data, unless arranged with Operating Data Owner or an 
Operating Data Owner representative in advance.  
c) The use of this Data prohibits any and all persons from learning the identity of any subject that 
may be represented in the Data.  
d) Scholarly communication must acknowledge explicitly the Operating Data Owner as the source of 
the Data. In addition to full citations, acknowledgements should include that “Data has been 
supplied under such agreement”. While acknowledging the source of the Data, authors must 
indicate that the results or views expressed in scholarly communication are those of the 
author/authorized user.  
e) Data obtained by this agreement remains the property of the Operation Data Owner.  
f) The agreement shall remain in force for two years from commencement date, unless this 
agreement is terminated pursuant to clause (g). 
g) Agreement may be terminated, if either party breaches any of the provisions hereof and such 
breach shall not be remedied within thirty (30) days of written notice. 
 
Personal Identifiers: Data have been purged of name, address, social security number, and other direct 
personal identifiers to prevent individual identification. An identifier number was assigned to each 
participant to eliminate the need for identifying information. An encrypted electronic link file was 
maintained by the researcher to associate identification numbers with confidential identifying information. 
This link file was accessible only by the evaluator and research assistant. No individual identifiable 
information has been divulged in any evaluation reports or presentations. As an additional step to enhance 
confidentially and protection of research participants, a Confidentially Certificate (CC) was obtained from 
the Department of Health and Human Services (DHHS) that ensures confidentiality of research 
participants.  
 
I acknowledge that I have read and understand the terms and conditions of the agreement, and agree to 
abide by them. 
_____________________________________ 
Kathleen H. Darby, CMSW  (Recipient)        DATE             Michael Cartwright, Executive 
Director, DDM       DATE 
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VITA 
 
 Ms. Kathleen Darby has over 25 years experience in healthcare management, 9 
years of current research experience and 2 years of teaching experience in social work 
courses at both the undergraduate and graduate level. In addition, Ms. Darby has 
noteworthy experience in conducting and overseeing co-occurring substance and mental 
illness disorders, disability, and disease and pain management support groups. She has 
worked on various research projects integrating care and improving access to healthcare 
for individuals with co-occurring disorders. Ms. Darby is scheduled to defend her 
dissertation; Co-occurring Disorders: A Latent Class Analysis, in April 2007 and acquire 
her Ph.D. from the University of Tennessee, College of Social Work. 
 Ms. Darby is an active community advocate for the rights of the underserved in 
Middle Tennessee. She served as a board member of the Tennessee Chapter for the 
National Association of Social Workers (NASW) from 2000 to 2005. Other 
accomplishments include, over 20 years of community service experience, a Gloria A. 
Kimmel Student Award, Teachers Award from the Martha O’Bryan Center and the 
recipient of a Jefferson Scholar Award. 
